hg_150256.1

Basic information about the TSS

---

TSS ID: hg_150256.1 Species: human Chr: chr15		Start: 58933559 End: 58933638 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000492526.5 ENST00000557924.5 ENST00000249736.11 ENST00000559305.5 ENST00000480144.5 ENST00000628684.2 ENST00000559880.5 ENST00000558486.5 ENST00000560682.5 ENST00000559261.1 ENST00000560012.5 ENST00000484498.1 ENST00000474342.1 AK055195 AK291423 AK000867 AK131242 BC108656 Distance: 0 GeneID: 79811 HGNC/MGI_ID: HGNC:20709 UniProt_ID: H0YL55 H0YLE6 H0YLW7 H0YMR6 H0YMW8 H0YNF3 H7BXE3

Gene_name: SAFB like transcription modulator Gene_symbol: SLTM Gene_synonyms: FLJ13213 Met Gene_source: HGNC:20709

TATA-Box annotation

---

Distance to TSS:	80
Nearest PromoterID:	NM_001013843
Entrez ID:	79811
Nearest Unigene:	Hs.512932
Nearest Refseq:	NM_017968
Nearest Ensembl:	ENSG00000137776
Gene Name:	SAFB like transcription modulator
Gene Alias:	Met
Gene Description:	SAFB like transcription modulator
Gene Type:	protein-coding
CpG%:	0.12
GC%:	0.726368
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SLTM p2@SLTM p3@SLTM p4@SLTM p5@SLTM p7@SLTM p8@SLTM p9@SLTM p10@SLTM
Sample		p1@SLTM	p2@SLTM	p3@SLTM	p4@SLTM	p5@SLTM	p7@SLTM	p8@SLTM	p9@SLTM	p10@SLTM
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	31.75	18.90	3.90	1.17	0.39	0.78	0.39	0.19	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	26.30	20.43	3.24	1.82	0.40	0.81	0.61	0.40	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	30.86	17.36	4.05	1.93	0.19	1.16	0.19	0.19	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	26.82	15.18	1.25	1.66	0.00	0.42	0.21	0.00	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	28.35	18.67	2.70	0.45	0.45	0.67	0.22	0.00	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	23.64	14.15	4.26	2.71	0.39	0.00	0.19	0.00	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	41.40	20.48	3.70	4.58	1.53	0.44	0.87	0.65	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	36.09	23.01	1.45	2.42	0.73	0.48	0.00	0.24	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	33.34	18.81	2.14	0.21	0.43	0.21	0.43	0.21	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	57.38	34.78	2.32	1.16	0.58	0.58	0.58	0.00	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	42.04	35.98	2.02	4.04	0.40	1.62	1.21	0.40	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	43.50	42.69	2.44	0.81	2.03	0.81	0.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	15.47	9.67	1.13	0.00	0.64	0.32	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	13.68	6.77	0.30	0.15	0.75	0.00	0.00	0.45	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	16.69	6.81	0.66	0.00	0.44	0.22	0.66	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	11.82	7.04	0.75	0.50	0.25	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	15.73	5.24	0.87	0.00	0.44	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	16.87	5.06	2.53	0.42	0.42	0.00	0.00	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	14.40	6.93	0.00	0.53	2.67	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	17.45	7.37	0.60	0.75	0.30	0.00	0.45	0.45	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	14.43	7.89	0.67	0.67	0.13	0.00	0.00	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	15.71	6.56	0.17	0.52	0.52	0.52	0.17	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	11.76	8.01	0.52	0.13	0.52	0.26	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	17.96	8.01	2.18	0.49	0.00	0.00	0.24	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	20.38	3.10	0.52	0.26	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	18.99	7.60	0.63	0.00	0.32	0.32	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	21.98	9.34	0.00	0.00	0.55	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	15.56	9.19	0.71	0.24	0.47	0.00	0.71	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	13.73	6.95	0.97	0.48	0.32	0.00	0.00	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	16.65	5.25	0.36	0.00	0.72	0.18	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	19.05	9.63	0.63	0.42	0.21	0.21	0.21	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	17.19	7.82	0.78	0.78	0.59	0.20	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	14.14	7.60	0.84	0.21	0.63	0.42	0.42	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	26.23	8.58	0.82	0.66	0.49	0.00	0.00	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	15.71	8.23	0.93	0.19	1.12	0.19	0.00	0.19	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	19.74	6.71	0.57	0.77	0.19	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	22.69	8.18	0.61	0.61	1.64	0.20	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	18.94	8.06	0.40	0.40	0.60	0.00	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	24.85	14.05	1.35	0.81	1.89	0.27	0.00	0.27	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	26.89	11.52	0.96	1.20	0.24	0.24	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	18.59	9.65	0.24	0.24	0.47	0.00	0.24	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	22.40	6.88	0.59	0.73	0.88	0.00	0.00	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	17.93	10.54	0.42	0.42	0.63	0.42	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	19.58	7.87	0.35	0.52	0.70	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	32.93	11.85	0.80	0.40	0.60	0.00	0.40	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	24.66	11.63	0.00	1.16	0.93	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	17.99	6.72	0.24	0.48	0.72	0.00	0.00	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	25.93	10.73	1.19	0.60	1.19	0.00	0.60	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	24.18	7.90	0.00	0.24	0.24	0.00	0.00	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	21.84	9.10	0.61	0.00	1.21	0.61	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	27.67	10.66	0.82	1.23	1.64	0.41	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	25.13	12.68	2.00	0.44	1.56	0.00	0.22	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	573.68	167.91	167.91	69.96	13.99	0.00	83.95	27.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	23.78	9.58	0.35	0.35	0.00	0.71	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	20.55	8.95	0.33	0.33	0.66	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	73.83	28.52	8.39	7.55	0.84	4.19	3.36	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	33.52	13.78	1.84	1.38	0.46	0.00	0.46	0.00	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	28.52	10.05	0.32	0.65	0.00	0.00	0.32	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	22.80	9.96	1.28	0.32	0.00	0.32	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	30.49	13.52	0.31	2.51	0.63	0.63	0.31	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	21.15	8.46	0.71	2.12	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	22.99	8.97	1.12	0.56	1.12	0.00	0.00	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	53.34	21.50	3.98	3.18	0.80	1.59	0.80	1.59	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	28.54	12.23	0.34	0.68	1.70	0.68	0.34	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	25.99	14.95	0.65	0.32	0.97	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	14.20	8.16	1.06	0.71	0.35	0.35	0.00	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	614.23	145.48	48.49	64.66	16.16	0.00	64.66	32.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	339.59	142.15	71.08	31.59	7.90	15.79	15.79	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	17.06	12.19	1.46	0.49	0.98	0.49	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	17.36	6.45	0.50	0.00	0.00	0.00	0.50	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	17.36	11.73	0.00	0.47	0.47	0.00	0.00	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	18.88	16.23	1.32	0.99	0.66	0.00	0.00	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	17.01	13.61	0.93	0.62	0.93	0.31	0.31	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	12.84	13.45	0.61	0.00	0.61	1.22	0.00	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	19.16	5.86	0.32	0.16	0.48	0.32	0.48	0.32	0.16
Adipocyte - breast, donor2	11327-117E4	18.29	6.90	3.37	2.25	0.64	0.48	0.80	0.48	0.16
Adipocyte - omental, donor1	11473-119C6	22.77	9.41	1.02	0.76	0.64	0.13	0.00	0.25	0.00
Adipocyte - omental, donor2	11474-119C7	13.45	5.23	1.49	0.75	1.49	0.75	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	19.43	5.02	1.00	0.67	0.33	0.67	0.33	0.00	0.33
Adipocyte - perirenal, donor1	11476-119C9	10.21	4.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	7.70	5.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	14.00	6.32	1.81	0.90	0.00	0.90	0.00	0.00	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	14.08	8.52	1.56	0.52	1.22	0.87	0.17	0.35	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	24.25	12.32	0.39	0.59	1.37	0.00	0.59	0.59	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	24.19	7.98	0.00	0.00	1.29	0.51	0.00	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	22.30	7.53	1.12	0.56	1.12	0.28	0.00	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	30.57	12.93	0.59	0.59	0.00	0.00	0.59	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	35.79	21.56	2.57	1.29	2.01	0.32	0.32	0.32	0.40
Adipocyte differentiation, day08, donor2	13023-139D8	26.47	14.20	1.94	0.97	2.26	0.32	0.65	0.00	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	26.13	16.53	1.07	0.00	1.60	0.53	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	26.15	14.47	1.67	1.67	1.11	0.00	0.00	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	19.55	9.98	1.25	0.00	0.83	0.00	0.00	0.42	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	19.34	9.29	0.75	0.25	1.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	28.80	13.74	1.64	0.00	1.96	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	28.01	13.09	0.91	1.22	1.83	0.00	0.30	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	9.06	3.54	0.00	0.22	0.22	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	7.53	6.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	0.00	2.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	11.51	2.34	0.36	0.00	0.18	0.54	0.00	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	10.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	6.37	3.29	0.00	0.00	0.41	0.00	0.21	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	13.96	4.46	1.37	0.23	0.46	0.11	0.00	0.11	0.00
Anulus Pulposus Cell, donor2	11463-119B5	10.04	3.92	0.49	0.24	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	8.09	4.94	0.45	0.90	0.90	0.45	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	12.16	5.21	2.60	3.04	0.00	0.87	0.00	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	14.98	6.42	6.42	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	8.37	3.59	3.29	1.79	0.30	0.60	0.00	0.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	13.91	5.06	1.26	0.00	0.00	1.26	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	7.92	5.28	3.30	2.64	0.00	1.32	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	13.32	4.55	0.97	0.65	0.32	0.00	0.00	0.00	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	13.11	1.46	0.00	1.94	0.00	0.00	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	11.88	1.78	1.78	1.78	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	9.04	3.39	0.38	0.75	0.38	0.38	0.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	5.08	5.08	0.00	0.73	0.00	1.45	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	13.79	2.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	12.19	4.61	0.16	0.00	0.33	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	6.82	2.73	2.73	2.73	0.00	1.36	0.00	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	13.87	4.07	0.30	0.15	0.30	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	10.18	3.75	1.07	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	10.77	3.97	0.76	0.38	0.00	0.19	0.00	0.00	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	16.04	4.28	1.87	0.53	0.53	0.00	0.27	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	5.85	3.90	0.00	0.00	0.98	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	11.44	2.32	0.33	0.33	0.33	0.17	0.00	0.00	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	8.41	4.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	0.00	7.08	3.54	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	10.63	3.77	1.89	1.03	0.00	1.03	0.17	0.51	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	8.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	10.68	3.88	0.97	0.00	0.00	0.00	0.49	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	13.66	5.69	0.76	0.76	0.00	0.00	1.14	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	9.69	3.63	3.63	0.00	0.00	0.00	1.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	8.55	2.28	1.14	1.14	0.57	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	10.26	4.92	1.50	0.86	0.00	0.21	0.43	0.43	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	10.07	3.61	1.03	1.03	0.00	0.00	0.26	0.26	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	8.91	3.75	0.47	0.47	0.00	0.47	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	10.29	3.54	1.61	0.96	0.64	0.96	0.00	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	5.71	4.28	0.71	0.71	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	6.43	2.34	2.92	0.58	0.58	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	9.33	2.71	0.90	0.90	0.30	0.30	0.60	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	10.69	4.75	2.38	0.00	1.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	10.17	4.07	1.53	1.53	0.00	2.03	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	15.28	4.33	2.04	1.02	0.25	0.25	0.51	0.25	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	9.53	5.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	8.63	1.73	2.16	0.43	0.00	0.00	0.00	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	8.89	4.02	0.00	0.64	0.42	0.21	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	7.25	0.58	1.16	0.58	0.00	0.00	0.00	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	13.23	4.72	0.00	2.83	0.00	0.94	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	14.24	5.26	1.19	0.85	0.51	0.17	0.51	0.00	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	4.63	2.32	0.00	0.00	0.00	0.00	4.63	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	21.13	2.11	2.11	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	10.94	4.07	1.29	0.21	0.21	0.21	0.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	15.04	3.01	0.60	1.20	0.60	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	8.75	4.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	9.43	3.91	0.23	0.69	0.23	0.00	0.23	0.00	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	15.30	7.65	5.10	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	14.24	3.31	0.25	0.00	0.00	0.00	0.00	0.00	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	13.21	2.89	2.06	1.24	0.41	0.00	0.00	0.21	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	12.85	2.75	2.14	0.92	0.00	0.92	0.31	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	13.38	1.43	2.87	1.43	0.48	0.96	0.96	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	12.86	3.77	1.11	0.44	0.44	0.67	0.44	0.22	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	15.26	3.05	3.05	0.00	0.00	1.53	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	8.31	1.66	0.00	0.55	0.00	0.00	0.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	10.59	3.71	0.79	1.06	0.53	0.79	0.26	0.26	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	10.18	4.00	2.54	0.73	0.00	0.36	0.00	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	15.84	4.54	0.49	0.12	0.49	0.12	0.12	0.12	0.12
Astrocyte - cerebellum, donor2	11580-120F5	9.07	4.28	0.34	0.00	0.51	0.00	0.17	0.00	0.17
Astrocyte - cerebellum, donor3	11661-122F5	7.55	2.31	0.00	0.00	0.21	0.00	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	52.64	12.90	1.39	0.70	0.70	0.35	1.05	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	42.55	12.78	4.69	2.59	0.97	0.81	0.32	0.49	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	39.08	15.81	3.13	1.94	1.79	1.04	0.30	0.15	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	72.48	22.02	9.17	5.50	3.90	2.18	2.75	1.15	0.46
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	78.30	21.17	9.65	4.38	3.01	1.13	1.38	2.13	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	78.63	24.69	11.27	5.92	2.96	2.39	2.05	1.37	0.46
Basophils, donor1	12241-129G9	52.57	9.94	0.26	0.26	0.78	0.00	0.00	0.00	2.09
Basophils, donor2	12242-129H1	141.07	32.47	0.00	0.00	2.16	0.00	0.00	0.00	5.41
Basophils, donor3	12243-129H2	41.75	8.23	0.15	0.00	0.73	0.00	0.00	0.15	1.18
Bronchial Epithelial Cell, donor1	11511-119G8	5.61	3.23	0.22	0.00	0.43	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	5.03	5.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	14.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	17.57	7.53	0.00	0.00	1.26	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	7.90	4.37	0.21	0.00	0.21	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	8.75	8.29	0.23	0.00	0.46	0.00	0.00	0.23	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	12.96	7.20	5.40	2.52	0.54	1.80	0.18	0.18	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	102.54	24.94	13.60	8.55	6.60	1.03	0.93	1.34	0.93
Burkitt's lymphoma cell line:RAJI	10476-106I8	89.44	20.03	13.51	10.71	5.12	0.93	1.63	1.40	0.93
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	73.55	12.15	0.00	0.00	0.64	0.64	0.00	0.00	2.56
CD133+ stem cells - cord blood derived, pool1	12223-129E9	206.84	51.71	0.00	0.00	0.00	0.00	0.00	0.00	10.34
CD14+ Monocytes, donor1	11224-116B9	61.99	13.53	0.56	0.00	0.00	0.00	0.00	0.00	0.56
CD14+ Monocytes, donor2	11305-117B9	60.88	15.40	4.27	3.71	0.37	0.74	0.19	0.37	1.30
CD14+ Monocytes, donor3	11381-118B4	61.25	20.64	3.73	2.63	0.88	0.66	0.66	0.44	1.54
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	53.78	10.19	2.26	1.13	0.57	0.00	0.00	0.00	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	58.38	10.24	1.52	1.52	1.14	0.00	0.38	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	72.32	11.51	1.64	0.33	0.00	0.33	0.33	0.33	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	71.55	13.15	5.93	5.06	1.73	1.01	1.59	0.29	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	77.55	12.97	3.32	3.92	0.91	0.30	0.91	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	69.88	18.95	3.08	1.42	0.95	0.47	0.71	0.24	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	54.07	10.04	4.69	2.68	0.50	0.84	0.33	0.67	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	59.34	12.14	3.04	1.93	1.66	0.00	0.28	0.00	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	71.65	13.88	3.97	2.23	1.49	1.24	0.99	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	32.70	6.46	2.35	2.35	1.37	0.20	0.59	0.00	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	40.60	7.12	1.60	0.71	0.89	0.36	0.18	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	63.98	12.62	0.44	0.44	0.22	0.44	0.22	0.44	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	43.55	9.13	1.64	0.94	0.00	0.23	0.23	0.23	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	65.48	15.84	1.58	1.06	1.58	0.00	1.06	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	51.03	6.66	3.33	0.00	0.00	1.11	0.00	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	57.71	9.37	7.14	4.46	1.34	1.19	1.49	0.74	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	56.47	12.17	1.00	3.59	1.00	0.60	0.20	0.00	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	91.61	21.03	0.62	0.83	1.46	0.21	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	51.02	8.69	3.66	2.75	0.46	0.23	0.92	1.14	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	79.85	14.25	1.58	0.68	0.68	0.00	0.00	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	52.38	7.86	1.75	2.18	0.44	0.00	0.87	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	44.65	8.07	1.61	1.34	0.54	0.27	0.81	0.00	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	45.19	7.68	2.27	2.27	1.57	0.70	0.17	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	62.70	11.78	2.52	2.52	0.42	0.84	0.00	0.00	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	44.27	8.27	8.63	4.41	0.37	1.65	1.29	1.47	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	54.25	8.10	0.35	2.47	0.70	0.35	0.35	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	55.72	10.53	2.19	1.32	0.00	0.44	0.44	0.44	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	42.72	9.42	2.44	3.14	0.52	0.70	0.87	1.05	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	47.95	11.15	5.20	5.95	0.74	1.12	1.12	0.37	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	77.60	15.74	0.43	0.43	0.86	0.22	0.22	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	40.95	10.65	1.23	1.23	0.41	0.00	1.23	0.41	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	62.35	16.69	0.70	0.23	0.70	0.46	0.23	0.00	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	72.85	12.53	1.39	0.23	0.70	0.70	0.00	0.23	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	71.93	16.35	0.87	0.22	1.53	0.87	0.00	0.00	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	57.75	14.09	0.92	0.69	0.69	0.69	0.00	0.00	0.92
CD14+CD16+ Monocytes, donor3	11912-125G4	55.02	14.73	1.73	0.00	0.65	0.00	0.22	0.22	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	70.70	16.04	1.25	0.78	1.87	0.00	0.47	0.00	1.09
CD14+CD16- Monocytes, donor2	11799-124C8	67.59	12.23	1.75	1.05	1.22	0.00	0.17	0.35	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	127.09	34.11	1.11	3.12	0.89	0.67	0.67	0.22	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	64.30	13.01	0.77	0.26	1.02	0.26	0.00	0.00	1.02
CD14-CD16+ Monocytes, donor2	11800-124C9	63.89	13.39	1.76	0.22	1.10	0.44	0.22	0.00	0.66
CD14-CD16+ Monocytes, donor3	11911-125G3	72.22	20.84	1.68	0.00	1.47	0.42	0.21	0.00	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	91.45	28.45	0.00	0.00	4.06	0.00	0.00	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	77.29	18.98	1.36	0.68	4.07	1.36	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	101.49	26.93	2.07	0.00	9.32	0.00	1.04	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	132.19	22.92	1.07	0.53	5.33	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	114.72	32.70	0.54	0.00	6.43	0.00	0.00	0.54	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	115.12	20.36	0.70	0.70	9.13	0.00	0.00	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	83.93	17.26	1.57	0.00	1.57	0.00	0.00	0.00	1.57
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	100.19	26.37	0.00	0.00	3.95	0.00	0.00	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	119.18	39.45	5.75	4.11	0.82	0.00	1.64	0.82	0.82
CD19+ B Cells, donor2	11624-122B4	115.34	31.92	5.08	2.18	0.73	0.73	0.00	1.45	1.45
CD19+ B Cells, donor3	11705-123B4	99.45	30.29	4.04	2.02	3.03	0.00	0.50	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	203.24	36.37	8.89	8.08	3.64	1.21	1.21	0.81	2.02
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	114.25	19.58	1.60	0.40	2.00	0.80	0.00	0.00	1.60
CD34+ Progenitors, donor1	11545-120B6	72.29	13.05	1.00	0.00	1.00	0.00	0.00	0.00	2.01
CD34+ Progenitors, donor2	11625-122B5	110.11	24.72	0.56	0.56	1.12	0.00	0.00	0.00	2.81
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	69.14	14.65	1.13	0.38	2.25	0.38	0.00	0.00	2.25
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	92.67	12.85	0.45	0.45	2.48	0.00	0.00	0.23	3.61
CD4+ T Cells, donor1	11225-116C1	202.81	39.28	6.43	2.50	5.71	0.71	0.71	0.36	16.78
CD4+ T Cells, donor2	11306-117C1	121.86	28.78	12.25	5.51	2.45	2.45	0.61	2.45	12.86
CD4+ T Cells, donor3	11382-118B5	126.57	36.60	11.28	10.06	3.05	4.88	1.83	0.91	10.06
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	80.65	20.93	3.32	0.51	2.30	0.00	0.26	0.26	2.55
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	85.80	22.46	1.57	0.67	2.25	0.22	0.00	0.00	2.70
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	69.57	24.72	2.59	1.15	4.89	0.00	0.86	0.29	3.45
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	133.69	25.60	2.84	0.95	1.90	1.42	0.00	0.00	4.74
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	129.23	28.80	1.40	2.81	4.21	0.00	0.00	0.00	10.53
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	125.26	52.74	0.00	0.00	3.30	0.00	0.00	0.00	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	80.21	19.22	1.88	0.87	3.61	0.00	0.43	0.00	3.90
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	72.53	19.49	11.02	6.95	3.05	0.51	1.02	2.03	3.22
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	67.87	19.34	8.71	4.03	2.26	1.13	0.81	1.13	3.71
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	103.56	29.14	2.69	0.90	5.38	0.90	0.45	0.00	6.72
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	102.37	27.25	1.75	1.05	1.40	0.70	0.70	0.00	7.34
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	186.11	43.12	2.20	1.76	4.40	0.00	0.88	0.44	8.36
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	87.70	23.19	3.37	2.53	2.11	0.00	0.84	0.00	1.69
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	72.93	19.53	14.54	4.99	2.08	1.66	1.04	0.62	1.87
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	69.50	14.03	3.34	3.01	2.34	0.33	0.33	0.33	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	165.88	30.18	5.17	2.72	4.89	0.82	1.09	0.00	4.62
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	176.33	35.91	0.54	1.61	3.22	0.54	0.00	0.00	6.43
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	163.18	43.04	1.79	5.38	1.79	0.00	0.00	0.00	3.59
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	97.54	22.99	2.23	1.11	4.45	0.00	0.19	0.00	2.60
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	82.53	16.90	1.30	0.65	1.30	0.22	0.22	0.00	3.47
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	76.50	18.70	1.47	0.42	2.10	0.00	0.21	0.00	2.73
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	143.59	23.76	2.53	1.01	1.52	0.00	0.00	0.00	7.58
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	115.68	21.23	0.87	0.00	0.87	0.00	0.00	0.43	9.96
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	212.68	42.71	6.10	3.05	2.61	0.87	0.87	1.31	7.41
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	150.44	29.69	1.48	0.99	5.94	0.00	0.00	0.00	4.45
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	148.63	24.00	0.00	0.00	7.39	0.92	0.92	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	143.77	26.52	0.00	1.40	8.37	0.00	0.00	1.40	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	186.37	35.72	0.83	0.00	4.15	0.55	0.28	0.28	2.49
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	185.27	42.21	0.49	0.74	5.15	0.25	0.25	0.25	2.45
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	158.62	15.40	0.00	0.00	3.08	0.00	0.00	0.00	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	151.84	24.71	0.00	0.00	6.45	0.36	0.00	0.36	2.15
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	144.04	27.70	0.00	0.00	6.92	0.00	0.00	0.00	2.77
CD8+ T Cells, donor1	11226-116C2	157.48	33.07	3.93	2.95	4.58	1.64	0.65	0.33	5.89
CD8+ T Cells, donor2	11307-117C2	128.02	31.16	12.76	4.13	1.50	1.88	0.75	1.13	8.26
CD8+ T Cells, donor3	11383-118B6	147.20	37.62	11.61	4.54	3.28	4.04	2.27	1.51	12.37
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	30.51	5.05	1.61	1.15	0.69	0.69	1.15	0.00	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	34.03	5.75	2.88	1.44	0.24	0.00	0.00	0.48	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	31.19	6.02	3.28	1.09	1.09	0.55	1.09	0.55	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	40.23	7.21	1.20	1.20	0.00	0.30	0.90	0.00	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	32.40	7.44	0.72	2.40	0.24	0.24	0.24	0.00	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	29.79	5.00	0.45	0.91	0.23	0.00	0.23	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	37.81	8.47	2.61	1.96	1.09	0.43	0.22	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	37.37	8.42	1.58	1.58	0.00	0.53	0.53	0.00	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	35.41	8.44	2.35	0.70	1.17	0.47	0.23	0.00	0.70
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	37.73	7.25	2.72	2.42	0.91	1.81	1.51	0.60	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	36.60	7.84	4.07	2.32	0.00	0.29	0.29	0.29	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	34.10	10.39	0.53	0.80	0.80	1.07	0.53	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	63.04	13.13	0.00	0.00	0.00	0.00	0.00	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	59.21	17.31	0.00	0.00	1.37	0.00	0.00	0.00	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	60.42	11.19	0.00	0.00	0.75	0.00	0.75	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	30.25	4.32	0.72	0.36	0.72	0.36	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	31.07	5.75	0.86	0.58	0.00	0.29	0.58	0.00	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	25.22	3.54	0.94	0.24	0.94	0.47	0.00	0.00	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	45.32	7.92	2.22	0.95	0.63	0.63	0.32	0.32	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	46.13	8.30	1.85	0.31	0.31	0.62	0.62	0.31	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	35.26	8.34	0.64	0.64	0.96	1.28	0.32	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	49.72	11.09	1.15	0.76	0.00	0.00	0.76	0.38	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	44.53	13.40	1.97	1.18	0.39	0.39	0.00	0.00	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	43.12	10.59	2.27	1.51	0.00	0.00	0.76	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	71.46	43.36	5.62	2.41	0.80	0.80	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	65.75	39.17	1.40	2.10	1.40	0.70	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	81.14	40.07	3.01	3.01	1.00	1.00	0.00	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	42.04	7.31	0.00	3.66	0.00	1.83	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	20.75	5.93	1.48	0.99	0.49	0.00	0.49	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	11.58	3.26	0.63	0.00	0.42	0.00	0.21	0.00	0.00
Chondrocyte - de diff, donor1	11261-116G1	31.20	7.63	3.47	1.04	0.35	0.00	1.39	0.35	0.00
Chondrocyte - de diff, donor2	11338-117F6	13.50	4.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	17.52	4.44	3.41	1.14	0.57	0.34	0.46	0.23	0.00
Chondrocyte - re diff, donor2	11339-117F7	34.91	15.22	0.00	0.00	0.00	0.00	0.90	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	22.65	8.90	0.40	0.40	0.40	0.00	0.00	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	54.74	14.69	2.41	0.69	1.15	0.34	0.00	0.11	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	28.43	12.61	3.42	1.71	2.14	0.86	0.64	0.21	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	28.14	11.59	2.92	2.30	1.24	0.35	0.62	0.35	0.53
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	24.94	11.00	1.65	0.46	1.01	0.28	0.00	0.00	0.00
Corneal Epithelial Cells, donor1	11526-119I5	5.05	2.63	0.44	0.00	0.22	0.22	0.22	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	9.10	5.69	0.00	0.00	1.14	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	8.69	5.37	0.77	0.26	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	55.80	4.79	1.16	0.50	0.66	0.17	0.17	0.00	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	46.37	2.84	0.32	0.00	0.32	0.00	0.32	0.63	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	34.51	3.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	31.21	2.70	2.16	1.40	0.22	0.11	0.22	0.11	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	93.61	24.26	1.71	1.37	1.71	1.02	0.34	0.00	2.73
Dendritic Cells - plasmacytoid, donor2	11309-117C4	116.21	41.13	0.00	0.65	3.92	0.00	0.00	0.00	5.88
Dendritic Cells - plasmacytoid, donor3	11385-118B8	119.05	25.17	0.48	0.00	1.45	0.00	0.00	0.00	4.84
Endothelial Cells - Aortic, donor0	11207-116A1	11.01	2.50	0.00	0.00	0.67	0.17	0.00	0.17	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	7.04	4.69	0.00	0.00	0.59	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	9.33	2.26	0.28	0.28	0.57	0.00	0.00	0.00	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	10.22	5.11	0.00	0.00	0.39	0.00	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	9.02	4.36	0.29	0.00	0.29	0.00	0.00	0.29	0.29
Endothelial Cells - Artery, donor2	11341-117F9	21.65	7.06	2.12	1.65	0.00	1.65	0.47	0.24	0.47
Endothelial Cells - Artery, donor3	11413-118E9	9.29	3.51	0.00	0.00	0.70	0.00	0.00	0.00	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	19.06	7.09	0.44	0.00	0.66	0.00	0.22	0.00	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	15.21	7.61	0.61	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	28.75	8.74	0.28	0.28	0.00	0.00	0.00	0.00	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	9.21	2.67	0.00	0.30	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	8.33	4.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	5.81	1.84	0.99	0.14	0.28	0.28	0.28	0.14	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	27.61	12.00	0.80	1.60	0.80	0.40	0.00	0.80	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	5.77	3.14	1.05	0.52	0.52	0.00	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	51.56	12.80	1.24	1.12	1.37	0.25	0.25	0.75	0.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	28.68	8.04	0.65	0.87	0.87	0.22	0.65	0.00	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	38.35	12.95	0.85	0.49	0.12	0.24	0.37	0.12	0.12
Endothelial Cells - Vein, donor1	11267-116G7	7.96	5.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	8.38	2.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	12.87	5.81	0.63	0.16	0.16	0.00	0.00	0.00	0.47
Eosinophils, donor1	12244-129H3	76.23	15.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	72.61	28.05	0.00	0.00	3.30	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	35.67	32.10	0.00	0.00	3.57	0.00	0.00	0.00	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	4.40	2.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	2.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	16.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	17.24	4.11	2.05	0.82	1.23	0.41	0.41	0.41	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	3.72	1.97	0.00	0.33	0.00	0.00	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	10.62	2.49	0.76	0.33	0.76	0.00	0.11	0.11	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	26.68	5.46	2.43	0.73	0.73	0.36	0.12	0.24	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	56.09	18.97	1.09	0.96	2.18	0.14	0.00	0.00	0.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	13.71	3.90	1.27	0.74	0.42	0.32	0.42	0.11	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	54.28	15.81	2.11	1.58	1.32	0.00	0.26	0.00	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	23.59	11.29	1.99	0.33	1.00	0.00	0.33	0.33	0.66
Fibroblast - Cardiac, donor1	11268-116G8	13.16	2.72	0.00	0.00	0.91	0.45	0.00	0.00	0.45
Fibroblast - Cardiac, donor2	11345-117G4	11.37	3.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	13.09	3.31	1.26	0.32	0.16	0.47	0.00	0.16	0.00
Fibroblast - Cardiac, donor4	11452-119A3	46.07	10.61	0.00	0.00	0.61	0.00	0.30	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	27.28	10.15	0.38	0.51	0.89	0.00	0.13	0.13	0.25
Fibroblast - Cardiac, donor6	11460-119B2	27.44	9.10	0.76	0.30	0.76	0.15	0.15	0.30	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	12.33	5.23	0.27	0.13	0.27	0.00	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	13.37	4.31	0.86	0.00	0.00	0.43	0.00	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	16.11	11.72	2.93	5.86	1.46	2.93	1.46	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	12.92	5.77	0.46	0.23	0.46	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	22.05	5.60	0.51	0.00	0.85	0.00	0.00	0.17	0.00
Fibroblast - Dermal, donor1	11269-116G9	13.15	5.17	0.47	0.23	0.23	0.23	0.23	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	9.43	6.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	14.14	6.89	3.51	1.81	0.24	0.24	0.85	0.24	0.24
Fibroblast - Dermal, donor4	11450-119A1	29.05	16.50	0.45	0.34	1.24	0.34	0.00	0.00	0.11
Fibroblast - Dermal, donor5	11454-119A5	38.21	17.79	0.87	0.70	1.74	0.35	0.00	0.00	0.17
Fibroblast - Dermal, donor6	11458-119A9	39.63	19.17	0.16	0.32	1.79	0.16	0.32	0.16	0.65
Fibroblast - Gingival, donor1	11237-116D4	37.06	13.74	1.04	0.42	0.62	0.00	0.21	0.00	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	30.39	8.91	1.05	0.26	0.79	0.52	0.52	0.00	0.00
Fibroblast - Gingival, donor2	11318-117D4	28.86	13.18	5.27	3.03	1.71	1.45	0.92	0.53	0.26
Fibroblast - Gingival, donor3	11394-118C8	27.36	11.89	0.68	0.39	0.77	0.10	0.19	0.10	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	16.62	4.16	0.00	1.04	1.04	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	10.92	5.99	2.47	1.06	0.53	1.06	0.35	0.35	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	40.53	10.45	2.34	1.56	0.62	0.62	0.62	0.16	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	28.80	8.11	2.03	1.35	0.95	0.27	0.14	0.27	0.54
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	11.65	2.12	0.35	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	36.12	9.51	2.78	1.17	0.29	0.29	0.44	0.15	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	42.81	9.82	2.32	1.91	0.82	0.00	0.41	0.41	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	42.67	12.07	0.55	0.44	0.55	0.44	0.44	0.11	0.33
Fibroblast - Gingival, donor9 (control)	11927-125I1	25.68	8.36	0.59	0.15	0.73	0.15	0.15	0.29	0.00
Fibroblast - Lung, donor1	11270-116H1	16.31	6.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	34.32	11.94	1.49	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	12.87	7.81	1.48	0.42	0.00	0.21	0.63	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	7.50	4.17	0.00	0.00	0.83	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	2.80	1.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	4.20	1.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	16.24	4.47	0.00	0.00	0.81	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	3.99	3.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	46.17	14.74	3.88	1.75	0.97	0.39	0.39	0.78	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	46.26	18.81	1.52	1.21	1.67	0.46	1.06	0.30	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	56.91	20.81	0.61	0.00	1.22	0.00	0.00	0.00	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	19.08	7.25	0.76	0.38	0.00	0.00	0.00	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	12.96	5.40	0.81	0.00	0.27	0.27	0.00	0.27	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	14.50	6.49	0.70	0.12	0.70	0.00	0.12	0.12	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	24.54	6.19	1.55	0.55	0.55	0.00	0.00	0.22	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	10.97	3.86	0.00	0.00	0.20	0.00	0.00	0.00	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	8.69	7.35	0.67	0.67	0.67	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	16.21	3.95	0.00	0.00	0.79	0.00	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	77.20	17.66	4.76	5.16	1.59	0.40	0.40	0.00	0.99
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	28.42	4.62	2.66	0.00	0.53	0.00	0.18	0.36	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	33.11	6.70	2.56	1.18	0.59	0.39	0.20	0.39	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	39.41	9.03	1.81	0.90	0.60	0.30	0.00	0.00	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	31.63	8.20	1.30	0.32	0.86	0.32	0.22	0.00	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	61.50	14.68	2.02	4.30	1.01	0.76	0.00	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	22.31	6.40	0.66	0.66	0.66	0.49	0.16	0.33	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	73.39	13.43	4.61	2.61	0.80	0.20	0.20	0.00	0.80
Fibroblast - skin normal, donor2	11561-120D4	27.73	7.03	0.60	0.80	0.80	0.40	0.00	0.10	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	76.77	13.90	3.32	3.32	1.81	0.00	0.00	0.00	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	28.83	6.21	1.08	0.75	0.91	0.25	0.25	0.17	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	28.89	6.15	0.85	0.85	0.34	0.51	0.17	0.00	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	52.55	11.17	0.99	0.99	0.33	0.33	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	23.86	7.56	1.17	0.75	0.64	0.43	0.00	0.21	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	19.57	7.08	1.86	0.67	0.84	0.51	0.00	0.00	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	12.08	3.92	0.78	0.94	0.47	0.16	0.47	0.00	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	398.88	110.80	0.00	22.16	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	72.34	17.43	1.74	0.00	1.74	0.87	0.00	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	23.75	8.84	0.52	0.52	0.52	0.35	0.17	0.00	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	31.75	12.75	1.04	0.26	1.30	0.00	0.00	0.26	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	30.66	12.01	0.77	0.00	0.77	0.26	0.26	0.26	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	55.89	14.55	2.30	0.00	1.53	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	55.51	14.04	1.28	0.00	0.64	1.28	0.00	0.64	1.91
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	86.72	48.78	8.27	7.42	1.14	2.28	2.57	3.71	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	41.64	21.78	9.65	3.86	1.10	2.48	0.55	2.21	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	46.35	15.98	5.94	3.42	1.14	1.83	1.60	0.91	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	63.40	30.51	14.46	5.55	3.76	1.98	1.59	2.18	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	42.03	19.03	6.61	3.70	1.32	1.06	1.85	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	54.79	15.00	4.24	2.61	1.30	1.30	0.33	0.65	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	93.75	35.38	19.46	11.50	3.10	4.86	2.65	3.54	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	40.56	19.22	5.09	2.54	1.13	1.41	0.14	1.84	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	35.34	19.21	4.06	3.08	0.99	0.37	0.62	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	57.75	16.12	8.06	4.30	2.95	2.42	1.61	0.54	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	26.27	14.74	3.84	3.10	0.74	0.87	0.99	0.50	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	26.72	13.98	4.84	3.46	0.55	0.42	0.69	0.69	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	40.66	14.23	4.68	2.24	1.22	0.41	2.03	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	28.98	9.13	1.14	0.91	0.46	0.23	0.68	0.46	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	21.18	11.34	2.74	2.37	0.62	0.87	0.50	0.12	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	29.07	8.74	2.19	1.53	1.31	0.22	0.00	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	19.50	9.75	2.66	0.89	0.59	1.18	0.30	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	31.16	11.60	5.25	3.81	0.79	1.43	0.32	1.11	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	26.36	8.49	3.57	1.56	1.34	0.67	0.67	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	29.44	10.69	2.82	0.81	1.21	0.40	0.20	0.60	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	30.71	14.25	4.92	3.73	0.85	0.17	1.36	0.34	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	62.96	13.39	2.48	1.15	1.15	0.18	0.44	0.09	0.18
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	38.81	11.13	0.73	0.62	0.83	0.10	0.00	0.10	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	45.94	12.47	0.68	0.17	0.85	0.34	0.00	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	26.22	11.51	1.99	1.77	0.44	0.22	0.44	0.22	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	47.01	12.23	2.08	0.50	1.16	0.25	0.33	0.08	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	49.62	13.88	1.02	0.20	0.82	0.41	0.20	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	23.93	9.28	3.09	1.24	0.21	0.21	0.21	0.21	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	20.64	11.18	3.34	3.23	0.58	0.58	0.12	0.46	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	28.35	7.00	3.00	1.50	0.83	0.50	0.33	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	24.91	5.95	2.20	2.20	0.22	0.66	0.66	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	17.83	11.56	2.09	1.23	0.49	0.61	0.12	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	33.55	14.26	5.35	2.27	1.13	0.49	0.49	0.32	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	19.56	10.58	3.21	1.28	0.64	0.00	0.00	0.64	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	16.77	9.48	2.27	2.27	0.47	0.19	0.47	0.19	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	21.51	7.75	2.69	1.42	0.95	0.63	0.32	0.47	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	20.37	9.73	3.65	2.43	0.61	0.61	0.30	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	21.12	11.60	1.88	1.25	0.31	0.73	0.00	0.21	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	18.88	8.12	1.54	0.44	0.44	0.22	0.22	0.88	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	23.57	12.91	5.05	3.37	0.56	0.84	0.28	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	22.31	8.70	0.46	1.48	0.37	0.46	0.00	0.37	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	23.26	9.63	4.28	1.87	0.53	0.27	0.00	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	29.53	8.72	2.45	2.60	0.77	0.61	0.61	0.46	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	20.86	8.16	1.55	1.55	0.65	0.39	0.00	0.26	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	15.18	7.86	0.54	1.08	0.27	0.27	0.54	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	21.38	6.27	4.42	1.47	1.66	0.37	0.18	0.18	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	20.62	5.48	2.63	0.66	0.66	0.00	0.00	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	26.78	11.90	0.00	0.00	0.99	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	25.46	8.57	1.85	1.32	0.79	0.13	0.53	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	22.80	7.67	2.82	0.20	0.40	0.61	0.20	0.40	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	44.48	19.32	1.27	1.02	0.76	0.00	0.00	0.00	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	112.87	34.64	4.98	3.78	3.38	2.39	0.20	0.40	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	47.30	23.11	6.16	3.39	1.54	2.31	0.77	1.08	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	91.65	31.71	6.75	5.52	3.07	1.43	0.20	1.02	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	50.07	14.71	1.25	0.94	2.19	0.31	0.31	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	53.40	15.26	0.57	0.85	1.41	0.00	0.28	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	98.24	28.59	7.84	9.69	0.92	2.31	1.38	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	59.40	14.85	4.95	4.95	0.00	2.47	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	71.95	17.79	5.03	3.87	1.16	0.77	0.77	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	67.39	19.25	8.02	4.81	1.60	1.60	0.00	1.60	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	55.64	12.17	20.87	5.22	0.00	5.22	1.74	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	67.05	15.62	3.91	4.56	0.65	1.95	0.98	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	67.54	18.94	7.00	4.12	1.65	1.24	0.82	1.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	69.98	33.32	13.33	36.65	0.00	10.00	3.33	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	57.33	15.10	8.11	3.08	1.12	1.12	1.12	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	63.73	13.40	8.17	4.25	0.33	1.63	0.65	0.98	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	70.46	17.62	13.42	7.55	0.84	6.71	0.84	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	61.07	18.13	3.50	3.50	2.54	0.00	0.64	1.59	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	62.84	13.59	5.77	3.74	0.00	0.68	1.02	1.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	50.12	12.53	12.53	2.09	0.00	6.26	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	37.80	24.63	5.15	2.29	1.15	0.57	1.15	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	32.56	12.43	7.99	3.26	0.89	0.59	0.59	0.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	50.82	10.16	6.78	5.08	1.69	1.69	1.69	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	56.33	16.98	6.63	2.90	0.83	1.24	0.41	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	58.22	15.19	6.90	3.22	1.15	2.30	1.61	0.92	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	31.61	10.54	15.81	5.27	0.00	0.00	0.00	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	52.66	9.99	4.23	1.54	0.38	0.77	0.77	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	50.85	12.71	4.89	2.28	1.96	0.65	1.63	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	35.45	14.05	1.34	0.00	1.34	0.00	0.67	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	43.54	14.64	5.01	1.93	1.16	1.16	0.39	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	60.59	18.49	7.87	4.11	0.34	0.68	0.34	0.34	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	12.42	9.94	12.42	4.97	0.00	2.48	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	31.61	17.46	4.72	2.36	0.47	1.89	1.42	0.94	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	31.38	15.69	5.43	3.62	0.60	0.00	1.81	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	30.01	15.26	0.00	0.51	1.02	0.00	0.00	0.51	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	48.66	12.76	5.18	2.79	0.40	0.80	0.80	0.80	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	39.96	15.29	8.88	1.97	1.48	0.99	1.48	0.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	31.87	38.95	1.18	3.54	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	39.67	23.92	4.67	4.08	0.58	0.58	0.58	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	25.46	21.51	2.19	3.07	1.76	0.88	0.88	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	40.69	16.11	7.63	7.63	0.00	1.70	0.85	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	37.61	11.34	2.98	2.39	1.79	1.19	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	37.36	8.25	6.79	2.43	0.00	2.91	0.49	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	5.71	4.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	13.31	5.82	2.49	0.42	0.00	0.42	0.42	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	14.62	4.50	0.00	0.00	0.00	0.00	0.00	0.00	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	8.25	3.81	3.49	0.95	0.00	0.00	0.95	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	7.52	5.85	0.84	0.42	0.00	0.42	0.00	0.84	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	24.60	6.85	4.18	1.97	0.93	0.58	0.81	0.46	0.23
Hep-2 cells mock treated, biol_rep2	11899-125E9	28.36	9.62	4.22	2.53	1.01	0.34	0.00	0.84	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	26.85	9.10	3.87	2.50	0.91	0.23	0.23	0.00	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	23.17	5.36	4.92	3.28	0.33	1.20	0.44	0.22	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	26.86	7.52	2.79	0.86	0.86	0.43	0.00	0.21	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	26.91	7.97	3.66	1.94	1.29	0.65	0.22	0.43	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	20.67	5.23	3.86	1.62	0.37	1.12	0.37	0.25	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	25.56	4.97	3.95	1.37	1.03	0.51	0.34	0.51	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	16.34	9.29	1.92	1.60	1.28	0.32	0.32	0.00	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	5.60	2.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	6.06	3.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	10.58	7.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	7.76	4.59	0.35	0.00	0.35	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	9.44	4.36	0.00	0.00	1.45	0.00	0.00	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	14.69	5.42	1.22	1.22	0.00	0.70	0.17	0.17	0.35
Hepatocyte, donor1	11523-119I2	41.16	7.26	3.63	1.21	0.00	1.21	0.00	1.21	0.00
Hepatocyte, donor2	11603-120I1	50.63	14.01	5.39	1.08	2.15	1.08	0.00	0.00	1.08
Hepatocyte, donor3	11684-122I1	49.08	15.34	8.59	7.36	0.61	0.61	1.84	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	127.27	15.01	7.18	1.96	4.57	1.96	3.92	1.96	3.26
Intestinal epithelial cells (polarized), donor1	11246-116E4	65.72	15.03	3.15	0.52	2.62	0.35	0.87	0.35	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	15.37	7.13	0.82	0.27	0.55	0.14	0.00	0.41	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	19.10	22.29	0.00	0.00	3.18	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	20.03	0.00	0.00	6.68	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	9.69	1.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	15.02	7.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	11.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	12.81	17.94	0.00	0.00	2.56	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	18.28	9.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	14.62	8.12	0.00	0.00	0.00	0.00	0.00	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	16.67	6.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	10.89	14.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	21.18	6.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	13.30	2.22	0.00	0.00	1.11	0.00	0.00	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	10.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	11.34	3.15	0.00	0.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	20.11	4.64	0.00	0.00	1.55	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	14.63	0.00	0.00	14.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	12.92	7.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	19.32	4.83	0.00	0.00	0.00	0.00	0.00	0.00	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	11.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	18.74	11.41	0.00	0.00	2.44	0.00	0.00	0.00	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	8.40	3.36	0.00	0.00	0.00	0.00	0.00	0.00	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	28.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	12.06	7.23	0.00	0.00	0.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	19.39	5.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	15.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	8.50	7.55	0.00	0.00	0.47	0.47	0.00	0.00	0.94
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	10.88	2.72	0.00	0.00	0.00	0.00	0.00	0.00	1.81
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	11.84	2.15	0.00	0.00	0.00	0.00	0.00	0.00	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	21.60	8.89	0.00	0.00	1.27	0.00	0.00	0.00	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	49.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	10.84	6.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	21.87	5.47	0.00	0.00	0.00	0.00	0.00	0.00	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	15.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	10.71	5.71	0.00	0.00	0.71	0.71	0.00	0.00	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	36.50	19.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	83.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	8.64	7.10	0.31	0.00	0.31	0.00	0.00	0.00	0.93
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	14.05	8.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	15.72	9.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	15.99	6.95	0.70	0.70	0.70	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	22.13	13.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	22.69	9.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	6.98	12.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	11.25	11.25	0.00	0.00	2.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	6.97	6.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	14.93	13.87	0.00	0.00	1.07	0.00	0.00	0.00	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	12.47	13.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	22.80	5.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	8.28	1.84	0.00	0.00	0.92	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	9.08	9.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	18.63	18.63	0.00	0.00	0.00	0.00	0.00	0.00	6.21
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	8.46	7.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	20.89	7.51	1.31	0.73	0.57	0.24	0.24	0.33	0.08
Keratinocyte - epidermal, donor2	11349-117G8	2.93	1.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	24.14	12.02	4.92	2.65	1.04	1.33	0.76	1.14	0.00
Keratinocyte - oral, donor1	11251-116E9	28.38	9.19	3.18	1.02	0.68	0.45	0.23	0.45	0.00
Keratocytes, donor1	11527-119I6	15.82	5.50	0.34	0.34	0.34	0.00	0.00	0.34	0.00
Keratocytes, donor2	11607-120I5	9.37	1.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	12.45	10.08	2.96	0.40	0.79	0.20	0.20	0.20	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	43.96	21.98	4.40	0.00	2.20	0.00	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	19.42	9.71	1.08	2.16	2.16	1.08	1.08	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	31.02	8.77	1.15	0.69	0.81	0.35	0.12	0.23	0.23
Lens Epithelial Cells, donor3	11690-122I7	19.88	5.85	0.61	0.20	0.61	0.00	0.00	0.10	0.30
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	8.42	3.08	0.36	0.24	0.24	0.00	0.00	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	4.74	2.23	0.28	1.40	0.28	0.56	0.00	0.28	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	16.69	4.88	4.56	2.20	0.00	1.10	0.94	0.63	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	6.45	4.30	1.08	0.00	0.54	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	8.51	2.52	0.95	0.00	0.32	0.00	0.32	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	5.18	1.83	1.08	0.54	0.43	0.43	0.11	0.32	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	10.26	2.46	1.23	2.87	0.82	0.41	0.00	0.00	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	2.78	1.26	0.25	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	6.47	2.67	1.69	1.69	0.00	0.99	0.42	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	5.54	5.14	0.40	0.79	0.40	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	10.08	4.85	1.55	0.39	0.39	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	3.15	1.11	0.19	0.00	0.19	0.19	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	6.27	4.88	2.09	0.70	0.00	0.00	0.00	0.35	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	7.63	3.34	0.95	0.48	0.00	0.00	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	6.87	1.65	1.65	0.14	0.27	0.41	0.14	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	9.24	6.16	3.39	1.54	0.92	0.31	0.62	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	4.99	3.12	0.00	0.31	0.31	0.62	0.00	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	5.67	1.65	0.73	0.00	0.37	0.00	0.00	0.18	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	10.20	4.61	1.65	0.33	0.00	0.66	0.00	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	7.91	3.51	0.88	0.00	0.00	0.59	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	4.73	1.49	0.50	0.00	0.00	0.75	0.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	11.15	5.33	0.00	1.45	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	8.08	1.62	0.27	0.27	0.00	0.00	0.27	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	7.27	2.12	1.51	1.51	0.15	0.45	0.00	0.00	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	10.37	5.18	2.59	1.04	0.00	0.52	0.00	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	12.35	3.14	3.35	1.26	0.63	0.42	1.05	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	6.62	1.05	0.60	0.45	0.15	0.30	0.15	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	12.38	5.50	0.00	0.69	1.38	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	7.15	3.20	0.75	0.38	0.19	0.38	0.19	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	4.88	1.06	0.85	0.11	0.32	0.00	0.21	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	11.15	4.36	3.39	0.00	0.00	0.00	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	6.28	1.98	0.99	0.33	0.00	0.33	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	3.96	1.36	0.99	0.37	0.25	0.37	0.25	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	12.22	6.29	3.33	1.11	0.74	0.74	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	8.40	5.19	0.74	0.25	0.00	0.25	0.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	3.02	1.51	0.14	0.27	0.41	0.00	0.00	0.14	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	12.87	3.86	2.57	1.93	0.32	0.64	0.32	0.64	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	13.69	6.09	1.52	0.00	1.52	0.61	0.00	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	8.96	4.34	2.10	1.54	0.56	0.70	0.28	0.14	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	5.69	2.84	1.78	0.71	0.36	0.71	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	6.30	2.91	0.48	0.48	0.00	0.00	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	4.05	1.56	0.31	0.31	0.00	0.16	0.00	0.16	0.47
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	8.95	2.15	1.07	0.72	0.72	0.36	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	5.88	1.96	0.33	0.00	0.98	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	2.83	0.71	0.47	0.24	0.24	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	9.53	2.48	0.99	0.12	0.12	0.12	0.12	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	5.63	2.31	0.26	0.26	0.00	0.00	0.00	0.00	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	6.86	2.69	0.30	0.00	0.30	0.30	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	22.66	4.53	0.00	0.00	0.00	0.00	0.00	0.00	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	24.55	2.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	14.84	6.68	1.48	0.00	0.74	0.00	0.00	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	24.54	5.08	0.00	0.00	0.85	0.00	0.00	0.00	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	18.99	4.92	0.00	0.00	0.00	0.70	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	14.01	3.74	0.00	0.00	1.87	0.00	0.00	0.00	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	24.73	6.70	0.52	1.03	2.06	1.03	0.52	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	21.41	4.76	0.00	0.00	1.19	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	21.49	4.98	0.00	0.00	0.45	0.00	0.00	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	28.79	5.53	1.16	1.16	1.74	0.58	0.29	0.29	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	26.56	4.50	1.35	0.90	0.45	0.45	0.90	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	25.47	5.83	0.54	0.14	0.68	0.14	0.00	0.00	0.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	24.14	4.11	2.57	1.03	1.03	0.00	0.00	0.51	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	23.64	3.53	1.06	1.06	0.00	0.00	0.00	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	17.32	8.66	2.00	1.33	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	34.13	5.60	3.57	0.51	1.02	0.51	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	26.95	7.47	2.13	0.27	1.07	0.27	0.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	31.74	6.99	0.94	0.19	1.13	0.57	0.38	0.57	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	24.54	5.52	0.00	0.00	0.61	0.00	0.00	0.00	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	30.99	8.97	1.63	0.82	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	35.82	6.66	2.08	1.46	1.46	0.83	0.83	0.42	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	30.27	7.29	3.64	1.68	2.24	0.56	0.84	0.28	1.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	22.67	5.15	0.00	1.03	2.06	0.00	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	24.68	6.68	2.32	2.32	0.58	1.74	0.58	0.00	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	32.28	5.38	2.09	1.49	0.90	0.30	0.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	26.56	5.53	1.66	1.11	0.55	0.55	0.55	0.00	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	20.86	7.07	0.35	0.00	1.41	0.35	0.35	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	26.18	4.06	1.11	1.84	1.11	0.37	0.37	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	10.36	1.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	23.41	5.37	0.00	1.15	1.54	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	28.31	5.10	1.13	0.00	1.13	0.00	0.00	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	19.69	5.74	1.64	0.00	0.82	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	26.21	4.52	0.90	0.45	0.45	0.00	0.45	0.45	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	27.29	1.44	0.00	0.00	0.00	0.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	29.13	5.23	0.00	0.00	0.75	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	21.92	2.97	0.37	0.37	0.00	0.00	0.37	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	28.43	7.32	0.43	0.86	1.29	0.43	0.43	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	17.13	5.99	1.71	0.86	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	23.99	5.33	0.67	0.67	1.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	24.74	7.84	0.00	0.00	0.60	0.60	0.00	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	28.44	4.98	0.00	0.00	1.42	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	17.53	6.87	1.03	0.69	1.03	0.69	0.00	0.00	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	26.84	7.51	2.68	0.54	0.54	0.54	0.54	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	24.91	4.71	1.35	0.00	0.67	0.00	0.00	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	23.71	2.96	0.74	0.74	0.74	0.74	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	25.58	3.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	23.27	6.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	18.81	4.80	0.00	0.40	0.40	0.00	0.00	0.40	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	34.16	8.72	0.00	0.00	0.73	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	32.19	7.67	0.00	0.00	2.30	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	30.58	7.40	0.49	0.49	1.48	0.49	0.00	0.00	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	26.35	8.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	29.16	9.05	0.00	0.00	2.51	0.00	0.00	0.00	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	25.69	5.86	0.00	0.00	0.00	0.00	0.00	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	17.21	6.88	0.00	0.00	0.00	0.00	0.00	0.00	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	24.05	5.34	0.89	0.00	1.34	0.45	0.89	0.00	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	25.42	5.08	1.17	0.78	0.78	0.39	0.00	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	24.41	5.94	1.98	0.66	0.66	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	21.28	6.75	0.00	0.52	1.56	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	25.82	6.13	0.44	0.44	0.44	0.88	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	27.40	1.68	3.91	0.00	1.68	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	16.78	3.09	0.44	0.00	1.32	0.00	0.00	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	24.69	6.56	0.77	1.16	1.16	0.39	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	30.89	5.57	0.51	0.51	1.52	1.01	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	22.11	2.88	1.92	0.48	0.48	0.00	0.00	0.48	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	25.84	5.17	0.40	0.00	1.19	0.40	0.00	0.00	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	23.70	7.90	0.61	0.61	0.61	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	18.68	4.15	0.00	0.00	0.00	0.69	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	22.80	5.32	1.52	0.00	0.76	0.38	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	22.21	3.61	0.52	0.00	0.00	0.00	0.00	0.00	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	10.28	3.02	0.60	0.00	0.60	0.00	0.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	21.23	6.34	1.58	0.95	0.95	0.63	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	21.86	8.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	14.94	4.02	0.00	0.00	0.57	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	21.08	4.63	0.00	0.00	1.03	0.00	0.51	0.00	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	24.05	4.95	0.00	0.00	0.71	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	13.05	1.70	0.57	0.00	0.57	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	14.14	4.16	0.83	0.00	0.83	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	18.79	3.92	0.78	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	15.45	1.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	17.66	5.11	0.00	0.00	0.00	0.00	0.00	0.46	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	22.08	2.01	0.00	0.00	0.67	0.00	0.00	0.00	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	17.64	6.42	1.07	0.00	0.00	0.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	17.38	4.85	0.00	0.00	0.81	0.40	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	20.19	5.51	0.00	0.00	1.84	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	13.34	4.45	0.00	0.00	0.00	0.00	0.00	0.00	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	18.81	3.99	0.00	0.00	0.00	0.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	21.47	5.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	16.96	4.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	12.03	4.01	0.00	0.89	0.45	0.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	17.16	3.12	0.26	0.00	0.26	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	19.89	3.32	0.00	0.00	0.66	0.00	0.00	0.00	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	18.71	2.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	36.01	5.47	0.91	0.23	1.37	0.00	0.00	0.00	0.46
Macrophage - monocyte derived, donor2	11313-117C8	33.21	2.57	0.73	0.37	0.37	0.00	0.37	0.00	0.18
Macrophage - monocyte derived, donor3	11389-118C3	27.53	3.54	0.79	0.79	0.66	0.26	0.13	0.00	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	19.12	4.25	0.53	0.00	0.53	0.00	0.00	0.00	1.06
Mallassez-derived cells, donor2	11929-125I3	36.92	11.73	3.64	1.27	0.95	0.32	0.00	0.00	0.48
Mallassez-derived cells, donor3	11930-125I4	31.83	14.59	2.22	1.67	0.97	0.42	0.00	0.14	0.42
Mammary Epithelial Cell, donor1	11273-116H4	25.11	9.77	5.88	3.09	0.50	0.20	0.30	0.10	0.00
Mammary Epithelial Cell, donor2	11350-117G9	26.06	9.27	5.50	2.32	1.16	0.29	0.29	0.29	0.00
Mammary Epithelial Cell, donor3	11422-118F9	8.48	1.75	0.00	0.00	1.00	0.00	0.00	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	315.24	86.10	0.00	2.03	5.42	1.36	0.68	0.00	2.71
Mast cell, donor1	11563-120D6	50.18	12.98	4.11	3.46	0.76	0.32	0.32	0.22	1.19
Mast cell, donor2	11565-120D8	84.10	22.29	1.78	0.59	0.89	0.30	0.59	0.30	0.30
Mast cell, donor3	11566-120D9	89.15	29.94	1.80	1.13	3.15	0.45	0.00	0.23	0.23
Mast cell, donor4	11567-120E1	81.02	24.11	0.71	0.35	1.60	0.18	0.18	0.18	0.89
Mast cell, expanded and stimulated, donor5	11940-126A5	102.24	17.08	5.54	3.44	2.11	0.44	1.11	0.55	1.44
Mast cell, expanded and stimulated, donor8	11942-126A7	74.71	10.51	3.50	2.33	0.00	0.58	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	48.30	13.08	1.61	0.80	1.49	0.34	0.00	0.23	1.03
Mast cell, expanded, donor8	11941-126A6	58.24	15.40	2.18	1.34	1.00	0.00	0.17	0.17	1.17
Melanocyte - dark, donor1	11502-119F8	19.90	7.26	0.80	0.50	0.40	0.30	0.10	0.10	0.10
Melanocyte - dark, donor2	11582-120F7	15.23	3.81	1.04	0.35	0.69	0.35	0.00	0.69	0.35
Melanocyte - dark, donor3	11663-122F7	31.44	6.88	3.19	0.94	0.94	0.22	0.36	0.14	0.07
Melanocyte - light, donor1	11274-116H5	8.46	1.18	0.00	0.24	0.47	0.00	0.00	0.00	0.00
Melanocyte - light, donor2	11351-117H1	7.51	0.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	6.07	0.87	0.87	0.87	0.00	0.00	0.87	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	14.37	7.81	1.15	0.62	0.73	0.31	0.21	0.42	0.21
Melanocyte, donor2 (MC+2)	12739-135I3	15.60	4.03	2.42	1.88	0.27	0.54	1.08	0.27	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	19.02	9.91	0.54	0.00	1.07	0.00	0.00	0.00	0.27
Meningeal Cells, donor1	11493-119E8	18.48	7.32	0.12	0.00	0.37	0.00	0.00	0.00	0.25
Meningeal Cells, donor2	11573-120E7	12.76	7.48	0.00	0.44	0.88	0.44	0.00	0.00	0.44
Meningeal Cells, donor3	11654-122E7	37.74	12.06	2.61	1.06	1.55	0.41	0.41	0.49	0.33
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	23.10	9.98	0.57	0.29	0.29	0.00	0.29	0.29	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	28.78	8.25	1.01	0.40	0.40	0.00	0.10	0.00	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	1.31	5.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	7.85	6.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	19.38	5.02	5.02	0.72	1.44	0.72	0.00	1.44	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	20.54	5.29	2.75	1.27	0.21	0.42	0.21	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	19.60	4.52	2.51	0.00	0.00	0.00	0.50	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	10.33	4.61	0.44	0.00	0.00	0.00	0.22	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	7.31	5.84	2.19	0.00	0.00	0.73	0.00	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	5.93	4.71	0.61	0.00	0.41	0.00	0.00	0.00	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	13.44	6.23	0.55	0.28	0.55	0.14	0.00	0.00	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	5.58	2.23	0.00	0.00	0.37	0.00	0.37	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	15.00	5.00	3.03	1.58	0.66	0.53	0.39	0.13	0.39
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	6.83	3.26	0.59	0.30	0.30	0.00	0.30	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	16.35	2.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	8.33	3.84	0.64	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	25.87	6.38	2.48	0.71	1.42	0.35	0.00	0.00	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	15.95	6.57	0.94	0.31	0.00	0.00	0.00	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	12.34	7.26	2.90	0.00	0.73	0.00	0.00	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	18.56	8.75	0.80	1.06	1.06	0.00	0.00	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	13.51	5.51	0.50	0.00	1.50	0.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	16.33	7.01	4.34	2.96	0.65	0.65	0.29	0.51	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	47.26	13.50	0.00	0.00	1.35	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	30.54	5.91	0.25	0.74	0.25	0.00	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	38.57	3.53	1.18	1.47	0.88	0.59	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	20.74	13.83	0.00	0.00	0.00	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	29.44	5.27	0.31	0.31	0.31	0.62	0.00	0.31	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	23.03	3.11	3.32	1.87	0.21	0.41	0.83	0.41	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	23.16	6.95	0.00	0.00	2.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	27.03	5.01	0.50	0.75	0.50	0.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	36.31	4.65	0.47	0.47	0.47	0.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	19.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	21.34	3.66	1.02	0.81	0.41	1.02	0.20	0.20	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	26.93	3.56	2.38	3.56	0.40	0.00	0.40	0.00	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	13.27	4.42	0.88	0.88	0.00	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	19.00	3.04	3.04	0.38	0.38	0.38	0.00	0.38	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	26.32	7.90	0.00	1.32	3.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	20.37	2.76	1.91	0.21	0.42	0.00	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	23.94	0.00	0.00	0.00	0.00	0.00	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	19.67	4.47	0.00	0.30	0.30	0.30	0.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	20.12	3.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	19.57	1.76	1.76	1.25	0.50	0.00	0.00	0.00	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	17.35	3.57	1.43	1.19	0.24	0.00	0.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	27.09	3.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	22.10	4.14	1.84	0.23	0.23	0.00	0.23	0.23	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	21.03	2.10	1.26	0.42	0.63	0.00	0.21	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	19.98	4.28	0.20	0.82	0.00	0.00	0.00	0.00	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	23.38	3.86	1.93	1.07	0.00	0.21	0.21	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	19.34	2.00	0.89	0.22	0.22	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	16.65	3.50	0.66	0.88	0.22	0.22	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	15.72	1.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	9.94	1.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	18.48	6.52	0.27	0.54	0.27	0.00	0.27	0.00	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	19.12	3.23	0.00	0.59	0.88	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	23.99	7.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	9.13	1.44	0.48	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	20.81	6.00	0.80	0.40	0.80	0.00	0.00	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	8.23	5.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	13.02	2.00	0.50	1.00	0.00	0.00	0.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	10.19	8.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	16.20	6.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	20.97	4.41	0.00	0.00	1.10	0.00	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	20.49	2.56	0.00	0.00	1.28	0.00	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	23.30	7.93	0.50	0.74	0.25	0.00	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	16.70	8.35	0.00	0.00	0.00	0.70	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	17.68	6.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	18.80	3.76	1.03	1.03	0.00	0.00	0.34	0.34	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	19.69	3.50	0.00	0.44	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	21.31	8.17	0.00	0.36	0.00	0.00	0.36	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	23.01	4.77	1.12	0.56	0.56	0.56	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	32.42	5.82	0.00	0.42	0.42	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	24.48	11.65	0.00	0.00	0.58	0.58	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	18.40	5.13	2.41	0.30	0.30	0.00	0.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	31.30	9.18	0.42	0.83	1.67	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	28.88	14.44	0.00	0.00	7.22	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	20.32	6.46	0.00	0.00	0.00	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	31.30	11.95	0.57	0.00	0.57	0.00	0.00	0.57	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	22.52	8.29	0.28	0.14	0.14	0.14	0.00	0.14	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	15.29	6.48	1.04	0.78	0.26	0.78	0.26	0.00	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	27.45	6.43	0.00	0.00	0.00	0.00	0.43	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	11.43	6.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	23.75	8.81	0.27	1.07	0.53	0.00	0.00	0.00	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	29.33	9.58	2.10	0.30	0.30	0.00	0.00	0.60	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	15.96	8.05	0.28	0.99	0.57	0.14	0.00	0.14	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	22.30	5.73	1.59	0.32	0.32	0.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	31.18	8.62	0.22	0.22	0.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	29.96	6.45	0.38	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	22.73	7.39	0.85	0.28	0.57	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	26.30	8.85	0.98	0.49	0.49	0.49	0.25	0.25	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	22.16	5.21	0.00	0.65	1.30	0.65	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	22.35	8.23	0.88	0.00	0.88	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	27.39	8.94	1.15	0.86	0.29	0.29	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	46.57	9.89	1.65	0.82	0.00	0.00	0.00	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	28.29	9.23	0.89	0.30	0.89	0.30	0.30	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	26.37	7.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	19.60	7.13	1.78	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	23.00	6.24	2.63	1.31	0.00	0.00	1.31	0.00	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	22.09	4.21	3.16	3.16	1.05	2.10	3.16	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	30.44	5.54	0.99	0.40	0.40	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	29.80	3.73	1.86	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	31.92	6.38	2.25	1.88	0.00	0.75	0.38	0.38	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	22.37	3.20	0.00	0.27	0.53	0.00	0.00	0.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	29.75	5.88	0.45	0.23	0.34	0.00	0.00	0.23	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	16.94	3.68	2.95	0.00	0.00	0.74	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	18.69	5.13	3.66	0.73	0.00	0.37	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	21.78	6.22	9.33	10.89	0.00	1.56	1.56	3.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	27.79	4.81	0.53	0.00	0.00	0.00	0.00	0.00	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	15.46	0.00	3.86	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	15.15	2.02	1.01	2.02	1.01	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	21.93	4.22	1.69	0.84	0.00	0.42	0.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	32.69	5.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	10.17	5.09	0.64	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	14.58	5.67	0.00	0.00	0.81	0.00	0.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	21.15	4.53	1.51	0.00	0.00	0.00	1.51	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	125.62	22.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	97.87	22.84	3.26	0.00	6.52	0.00	0.00	0.00	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	52.28	9.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	62.75	37.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	25.42	7.97	2.15	1.08	0.86	0.43	0.43	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	28.74	6.79	2.09	1.05	0.00	2.09	0.00	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	17.35	5.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	8.76	5.84	0.42	0.00	0.83	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	31.18	12.17	0.00	0.00	0.95	0.57	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	57.45	14.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	13.60	6.80	0.68	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	62.48	29.40	5.51	0.00	1.84	1.84	1.84	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	12.97	6.28	0.00	0.00	0.84	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	16.74	11.62	0.23	0.23	0.93	0.00	0.00	0.00	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	13.24	6.49	0.00	0.00	0.27	0.00	0.00	0.00	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	28.59	10.09	0.84	0.84	0.63	0.42	0.63	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	523.33	111.35	44.54	55.67	11.13	0.00	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	13.40	5.46	0.00	0.00	0.00	0.00	0.50	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	17.05	6.77	0.81	0.27	0.54	0.27	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	11.33	6.12	0.00	0.45	0.68	0.00	0.00	0.00	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	11.59	7.68	0.65	0.00	0.33	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	26.61	11.48	0.73	0.73	0.91	0.18	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	13.26	9.55	0.00	0.00	0.53	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	12.01	4.80	0.60	0.60	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	27.90	9.19	0.66	0.00	0.33	0.33	0.33	0.33	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	9.59	5.85	0.00	0.00	0.16	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	32.98	11.99	1.59	0.71	0.71	0.18	0.00	0.35	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	11.25	7.03	0.00	0.00	0.70	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	10.57	6.90	0.00	0.00	0.92	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	16.71	6.75	0.96	0.00	0.64	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	21.38	12.76	0.00	0.34	0.00	0.34	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	126.42	25.28	0.00	2.53	2.53	0.00	2.53	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	34.09	14.70	0.89	0.00	0.89	0.22	0.22	0.22	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	13.55	8.47	0.42	0.42	0.42	0.42	0.42	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	18.75	7.12	0.00	0.00	0.95	0.00	0.47	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	15.45	6.87	0.00	0.00	0.43	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	397.22	90.28	0.00	9.03	18.06	9.03	9.03	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	15.66	7.66	0.00	0.00	0.67	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	26.60	8.12	0.00	0.00	0.00	0.00	0.45	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	19.44	5.95	0.00	0.40	1.59	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	19.50	3.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	20.43	9.08	0.00	0.00	0.38	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	14.01	9.45	0.00	0.00	0.65	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	9.15	3.49	0.00	0.00	0.87	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	33.02	12.21	1.81	1.36	0.00	0.45	0.45	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	21.17	6.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	17.95	5.98	0.66	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	19.84	10.42	0.00	0.00	0.99	0.50	0.50	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	17.61	8.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	27.83	13.91	0.00	0.00	0.91	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	27.85	9.50	1.33	1.55	0.66	0.66	0.00	0.22	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	14.91	11.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	199.27	35.77	5.11	10.22	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	14.63	9.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	12.27	7.24	0.00	0.00	0.31	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	14.53	6.36	0.00	0.30	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	13.45	12.66	0.79	0.79	0.00	0.00	0.00	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	35.14	12.47	0.00	1.13	2.27	2.27	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	166.91	25.29	10.12	0.00	0.00	5.06	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	22.73	4.60	1.24	0.50	0.25	0.25	0.37	0.12	0.12
Myoblast, donor2	11322-117D8	27.81	7.29	3.07	1.53	0.77	1.92	0.96	0.19	0.19
Myoblast, donor3	11398-118D3	28.92	10.43	0.67	0.50	1.18	0.17	0.00	0.00	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	55.60	13.86	6.71	4.52	1.75	1.02	0.44	0.73	0.29
Natural Killer Cells, donor1	11230-116C6	157.14	35.67	6.46	4.00	3.08	0.31	0.00	0.31	8.92
Natural Killer Cells, donor2	11311-117C6	125.75	24.43	9.05	6.63	1.51	5.43	1.51	1.21	4.52
Natural Killer Cells, donor3	11387-118C1	129.94	33.68	9.94	6.44	2.76	2.39	0.74	1.10	8.28
Neural stem cells, donor1	11275-116H6	146.99	25.77	2.18	2.54	3.63	0.36	0.36	0.36	0.73
Neural stem cells, donor2	11352-117H2	102.06	25.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	52.34	17.07	4.55	2.28	0.00	0.00	4.55	0.00	0.00
Neurons, donor2	11574-120E8	46.45	12.11	2.42	1.10	1.10	0.22	0.00	0.00	0.88
Neurons, donor3	11655-122E8	56.73	18.09	4.11	1.64	0.00	0.00	0.00	0.00	0.82
Neutrophils, donor1	11233-116C9	50.11	30.62	6.50	4.64	5.57	0.93	0.93	0.93	0.00
Neutrophils, donor2	11314-117C9	40.58	5.80	11.60	0.00	2.90	2.90	0.00	5.80	0.00
Neutrophils, donor3	11390-118C4	76.36	38.48	1.22	0.61	1.83	1.22	0.00	0.00	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	15.55	5.22	1.66	0.47	0.47	0.36	0.00	0.00	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	8.14	4.88	0.98	0.98	0.33	0.00	0.00	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	7.02	4.61	0.60	0.20	0.20	0.40	0.20	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	18.17	5.23	3.03	1.24	0.28	0.69	0.28	0.41	0.14
Olfactory epithelial cells, donor2	11934-125I8	22.15	5.93	4.34	2.03	0.58	1.30	0.72	0.29	0.14
Olfactory epithelial cells, donor3	11935-125I9	18.27	6.36	2.61	1.59	0.79	0.23	0.34	0.45	0.00
Olfactory epithelial cells, donor4	11936-126A1	20.36	7.89	1.95	1.07	0.29	0.29	0.19	0.10	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	22.87	10.83	1.20	1.81	0.00	1.20	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	8.93	3.83	0.00	0.00	0.21	0.00	0.00	0.00	0.43
Osteoblast - differentiated, donor2	11353-117H3	8.00	2.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	16.14	0.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	6.64	0.98	0.00	0.00	0.59	0.00	0.00	0.00	0.00
Osteoblast, donor2	11354-117H4	44.25	7.73	4.21	0.70	2.11	0.70	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	12.09	3.20	0.18	0.00	0.89	0.00	0.00	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	32.77	6.15	3.20	1.18	0.76	0.08	0.34	0.42	0.00
Pericytes, donor1	11491-119E6	3.00	1.78	0.22	0.11	0.22	0.00	0.00	0.00	0.11
Pericytes, donor2	11571-120E5	4.30	2.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Pericytes, donor3	11652-122E5	6.92	4.07	0.41	0.20	0.00	0.41	0.00	0.00	0.00
Perineurial Cells, donor1	11499-119F5	23.06	9.27	2.03	0.34	0.90	0.11	0.23	0.45	0.00
Perineurial Cells, donor2	11579-120F4	25.76	7.27	1.29	0.18	0.46	0.00	0.28	0.00	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	142.80	29.96	5.10	3.82	4.46	0.32	0.64	0.00	3.51
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	84.48	21.30	1.47	0.98	2.45	0.98	0.49	0.49	1.47
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	98.74	20.32	1.68	1.04	1.42	0.52	0.65	0.13	2.59
Placental Epithelial Cells, donor1	11278-116H9	14.11	7.65	0.00	0.24	0.96	0.00	0.00	0.00	0.48
Placental Epithelial Cells, donor2	11355-117H5	9.98	7.76	1.11	0.00	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	9.23	3.53	0.59	0.00	0.20	0.20	0.00	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	6.65	2.22	0.95	0.00	0.95	0.00	0.32	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	22.89	6.00	0.94	0.94	0.94	0.19	0.19	0.00	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	51.17	9.40	2.22	0.65	1.70	0.13	0.13	0.13	0.13
Preadipocyte - breast, donor2	11328-117E5	16.66	5.85	1.80	0.45	0.45	0.23	0.23	0.23	0.45
Preadipocyte - omental, donor1	11468-119C1	20.78	6.07	1.28	0.32	1.07	0.21	0.21	0.11	0.11
Preadipocyte - omental, donor2	11329-117E6	27.50	7.86	2.62	0.44	0.44	0.44	0.44	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	21.20	7.59	3.01	2.29	0.72	0.29	0.86	0.72	0.00
Preadipocyte - perirenal, donor1	11469-119C2	2.95	5.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	8.60	2.76	0.00	0.00	0.31	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	33.64	10.80	4.96	4.43	1.42	1.06	0.35	0.53	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	18.56	4.94	1.02	1.02	0.34	0.00	0.00	0.51	0.00
Preadipocyte - visceral, donor1	11280-116I2	44.43	11.55	2.98	1.96	1.58	0.84	0.56	0.47	0.28
Preadipocyte - visceral, donor2	11357-117H7	31.75	5.98	4.60	1.38	2.30	0.46	0.46	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	24.45	10.03	2.30	1.15	0.52	0.10	0.42	0.31	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	46.92	9.96	2.56	1.51	1.06	0.45	0.15	0.30	0.00
Prostate Epithelial Cells, donor2	11331-117E8	14.62	5.55	1.35	1.35	0.41	0.27	0.00	0.00	0.14
Prostate Epithelial Cells, donor3	11404-118D9	14.27	25.47	9.25	5.08	1.59	2.39	1.84	1.41	0.12
Prostate Stromal Cells, donor1	11254-116F3	19.82	9.00	1.82	0.34	0.57	0.46	0.34	0.11	0.11
Prostate Stromal Cells, donor2	11332-117E9	20.26	10.76	5.38	3.23	0.72	1.26	0.72	0.72	0.54
Prostate Stromal Cells, donor3	11405-118E1	9.59	6.67	2.19	0.73	0.42	1.04	0.10	0.10	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	6.20	4.74	0.00	0.00	0.36	0.00	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	15.32	9.57	2.63	1.18	0.55	0.35	0.35	0.42	0.00
Renal Epithelial Cells, donor1	11517-119H5	11.16	7.61	0.00	0.00	2.03	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	7.11	5.69	0.71	0.00	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	20.01	8.68	2.65	2.22	0.32	0.32	0.53	0.42	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	7.49	4.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	5.12	2.70	0.13	0.40	0.00	0.13	0.13	0.00	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	29.75	9.32	3.77	1.55	0.00	1.55	0.89	1.33	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	3.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	8.58	3.74	0.22	0.22	0.44	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	11.29	3.76	0.00	0.00	0.00	0.63	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	4.99	3.05	0.00	0.00	0.28	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	14.49	8.32	0.54	1.61	1.07	0.27	0.27	0.27	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	5.90	5.48	0.00	0.00	0.42	1.27	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	11.57	6.17	0.39	0.39	0.00	0.19	0.00	0.19	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	17.89	7.52	1.56	1.30	0.26	0.52	0.26	0.52	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	10.80	4.83	0.57	0.28	0.57	0.00	0.57	0.28	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	11.32	3.09	1.03	0.00	1.03	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	26.09	9.03	2.26	0.75	0.50	0.00	0.00	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	71.09	12.29	4.54	1.87	2.00	0.00	0.40	0.13	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	62.54	23.23	3.57	1.79	3.57	0.00	0.89	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	105.67	14.86	50.63	23.67	0.55	6.60	3.85	0.55	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	169.38	49.88	7.54	4.06	3.48	1.16	0.58	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	76.84	21.71	1.69	1.69	1.43	0.65	0.00	0.13	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	41.01	10.82	6.45	3.38	0.70	1.19	1.09	1.39	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	70.16	12.72	3.23	1.00	1.34	0.33	0.11	0.22	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	68.47	17.74	9.92	5.09	2.48	1.61	1.12	0.87	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	42.42	12.35	8.27	4.55	1.28	0.82	1.52	1.05	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	68.88	15.72	18.26	12.48	2.31	2.31	1.62	1.62	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	48.33	13.69	3.56	2.74	0.96	0.27	0.82	0.27	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	47.65	12.40	6.20	3.63	0.91	2.42	1.36	0.76	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	58.77	14.69	0.72	0.18	0.18	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	43.18	11.91	3.44	4.45	0.43	1.00	0.72	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	42.50	10.73	5.37	3.33	0.64	0.32	0.75	1.07	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	38.94	12.83	4.65	3.54	1.11	0.22	0.66	0.22	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	56.21	17.59	3.44	1.53	1.53	0.38	0.19	0.00	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	46.02	11.37	3.17	1.86	0.75	0.84	1.02	0.47	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	102.97	18.98	8.83	7.33	2.44	0.75	1.50	1.69	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	49.10	12.21	1.46	1.06	0.66	0.40	0.40	0.53	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	52.17	13.04	8.18	3.80	0.78	2.63	1.07	0.78	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	55.00	12.99	6.68	5.92	2.67	1.91	1.34	1.72	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	46.56	12.92	1.50	1.17	0.75	0.32	0.64	0.32	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	49.05	10.93	5.61	5.33	0.84	0.84	1.12	1.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	61.52	17.09	7.35	4.44	1.88	0.51	1.20	1.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	46.13	8.39	1.64	0.91	0.73	0.18	0.18	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	43.41	11.16	9.69	6.01	1.23	1.72	0.74	0.98	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	54.40	13.57	5.91	3.63	1.48	0.67	0.67	0.27	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	50.24	12.27	2.83	5.19	0.94	0.94	0.94	0.24	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	45.83	9.52	7.74	2.98	0.40	1.98	0.79	1.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	55.19	12.86	9.82	6.31	1.17	1.64	1.40	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	37.12	14.31	4.15	1.45	0.41	0.62	0.00	0.41	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	50.21	13.05	4.20	1.77	0.88	2.43	0.44	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	49.30	10.44	2.51	1.67	1.25	0.42	0.21	0.63	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	42.93	12.92	4.85	2.96	0.67	0.81	0.13	0.40	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	45.81	13.28	1.53	1.53	0.85	0.68	0.17	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	56.87	11.76	6.94	4.63	0.96	0.77	1.74	0.58	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	51.75	14.27	3.95	3.95	0.52	0.34	0.69	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	48.42	11.80	1.92	1.78	1.37	0.69	0.69	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	61.73	15.27	7.39	7.72	1.97	1.31	1.15	1.64	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	48.40	13.12	2.05	3.24	0.85	0.17	0.34	0.17	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	47.35	13.32	11.69	5.33	1.18	2.52	0.74	1.63	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	62.11	19.72	4.00	1.60	1.33	0.53	0.53	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	38.71	17.42	1.80	2.90	1.38	0.28	0.14	0.55	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	44.53	10.48	5.48	4.52	1.19	1.19	0.95	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	77.19	19.95	5.04	2.22	2.42	0.60	0.81	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	40.78	10.74	2.64	2.54	0.28	0.75	0.57	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	58.69	18.87	24.11	14.32	2.10	1.75	2.79	1.75	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	59.54	13.60	6.04	1.51	0.30	0.30	0.60	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	43.57	12.73	2.45	1.22	1.96	0.37	0.37	0.61	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	196.93	41.19	2.33	1.02	4.80	0.29	0.58	0.87	0.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	51.72	18.86	4.87	1.22	0.61	0.00	1.22	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	44.00	13.56	1.81	1.51	0.60	0.30	0.00	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	46.59	10.40	3.85	3.62	1.13	0.68	0.45	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	70.69	23.66	7.19	3.89	1.80	0.60	0.60	1.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	47.47	12.52	1.30	2.01	1.42	0.47	0.12	0.24	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	40.55	11.74	0.00	0.43	0.64	0.00	0.21	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	73.92	28.85	1.80	1.80	1.20	0.60	1.20	0.00	0.00
Schwann Cells, donor1	11498-119F4	9.78	5.27	0.00	0.00	0.38	0.00	0.00	0.00	0.00
Schwann Cells, donor2	11578-120F3	6.80	0.00	0.00	0.00	0.00	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	12.27	6.13	1.31	1.53	0.66	1.10	0.44	0.66	0.22
Sebocyte, donor1	11220-116B5	16.98	4.93	0.00	0.00	0.55	0.00	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	12.87	2.30	0.92	0.00	0.46	0.00	1.38	0.00	0.00
Sebocyte, donor3	11378-118B1	5.57	3.30	0.21	0.21	0.21	0.00	0.41	0.00	0.21
Sertoli Cells, donor1	11255-116F4	38.10	6.63	0.00	1.66	0.00	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	28.24	5.65	14.12	8.47	0.00	0.00	0.00	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	29.12	10.38	2.82	0.88	0.88	0.09	0.09	0.09	0.09
Skeletal Muscle Cells, donor2	11358-117H8	7.95	2.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	10.03	7.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	28.59	10.21	0.63	0.63	1.10	0.31	0.00	0.16	0.00
Skeletal Muscle Cells, donor5	11455-119A6	30.62	11.30	1.04	0.45	1.19	0.15	0.00	0.15	0.00
Skeletal Muscle Cells, donor6	11459-119B1	28.47	16.16	0.92	1.08	0.62	0.15	0.15	0.15	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	45.49	12.10	4.79	2.27	1.76	0.63	0.25	0.50	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	25.68	10.84	2.85	1.43	0.43	1.28	0.29	0.00	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	32.24	13.00	2.28	1.09	1.09	0.50	0.30	0.40	0.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	29.99	6.66	3.29	2.11	0.84	0.25	0.08	0.17	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	7.24	5.07	0.00	0.00	0.72	0.00	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	10.46	2.89	0.00	0.00	0.41	0.00	0.00	0.00	0.14
Skin - palm, donor1	10286-104F7	88.64	24.17	0.00	2.69	0.00	0.00	2.69	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	9.80	3.60	0.43	0.00	0.14	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	202.02	92.42	1.64	0.00	0.00	0.00	0.00	0.00	2.45
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	12.07	4.54	0.00	0.26	0.26	0.00	0.39	0.00	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	29.05	12.79	3.89	1.67	2.22	0.28	0.00	0.28	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	23.91	5.77	1.13	0.70	0.28	0.42	0.42	0.14	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	156.47	45.67	2.33	1.27	6.13	0.42	0.21	0.21	1.90
Small Airway Epithelial Cells, donor3	11406-118E2	25.56	15.89	3.15	1.42	1.42	1.05	0.37	0.45	0.30
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	4.32	3.09	1.23	0.31	0.00	0.00	0.31	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	30.24	10.23	1.33	1.11	0.67	0.00	0.00	0.22	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	9.41	5.88	0.00	0.59	0.00	0.59	0.00	0.00	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	8.40	1.33	0.00	0.22	0.44	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	7.09	2.76	0.39	0.00	0.39	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	11.59	1.55	0.00	0.00	0.00	0.00	0.00	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	20.02	4.00	4.00	0.00	0.00	1.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	6.65	2.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	18.18	6.43	7.09	1.77	0.89	0.44	0.89	1.11	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	15.24	6.15	0.00	0.00	0.26	0.00	0.00	0.00	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	22.47	5.86	0.33	0.33	0.65	0.00	0.00	0.00	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	19.20	10.04	1.48	0.00	0.30	0.00	0.00	0.59	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	13.67	6.41	0.43	0.71	0.57	0.00	0.28	0.00	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	3.09	1.30	0.33	0.00	0.33	0.00	0.00	0.00	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	16.44	8.22	2.44	0.91	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	10.36	2.02	0.00	0.00	0.51	0.00	0.00	0.00	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	24.48	18.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	4.77	1.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	18.29	7.67	0.59	0.00	0.59	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	19.80	9.69	0.43	0.43	0.86	0.22	0.00	0.22	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	17.21	7.24	0.84	0.31	1.15	0.31	0.31	0.21	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	4.49	1.86	0.00	0.00	0.46	0.00	0.00	0.00	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	3.23	1.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	10.16	6.57	0.00	0.00	0.60	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	9.90	4.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	25.99	8.09	4.16	1.73	0.47	0.55	0.31	0.63	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	18.92	7.35	1.11	1.01	0.30	0.10	0.00	0.10	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	16.61	7.51	3.41	1.37	0.68	0.46	0.00	0.23	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	3.02	1.81	0.00	0.00	0.00	0.00	0.00	0.00	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	35.76	15.37	1.06	2.38	1.06	0.26	0.26	0.00	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	26.10	8.92	3.06	1.86	0.67	0.00	0.13	0.27	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	16.53	8.14	3.38	2.00	0.63	0.88	0.25	0.25	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	11.92	2.28	0.51	0.00	0.25	0.51	0.25	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	16.59	4.07	0.45	0.00	0.15	0.00	0.00	0.00	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	10.50	3.75	0.75	0.00	0.00	0.75	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	11.63	3.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	9.77	3.26	0.00	0.00	0.00	0.00	0.00	0.00	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	10.10	4.54	1.01	1.01	0.00	0.00	0.50	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	6.89	4.39	0.00	0.00	0.00	0.00	0.00	0.00	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	2.95	0.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	33.91	12.58	0.42	0.33	1.17	0.08	0.00	0.00	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	14.95	5.14	0.47	0.00	0.93	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	5.61	1.44	0.00	0.00	0.14	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	11.98	4.33	0.51	0.51	0.00	0.00	0.00	0.00	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	5.26	1.88	0.00	0.00	0.38	0.00	0.00	0.19	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	28.93	10.90	3.35	0.70	0.42	0.56	0.14	0.14	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	10.89	5.53	0.25	0.50	0.34	0.00	0.08	0.08	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	2.38	3.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	3.43	1.96	0.00	0.00	0.24	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	19.00	5.97	0.44	0.88	0.88	0.00	0.22	0.00	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	15.80	11.41	0.88	0.59	2.05	0.00	0.00	0.00	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	17.30	6.80	0.97	0.19	0.19	0.19	0.00	0.00	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	13.22	5.02	1.32	1.06	0.00	0.53	0.00	0.26	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	18.97	5.95	3.35	1.49	0.37	1.12	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	16.17	10.78	1.08	1.80	0.00	0.72	0.36	1.44	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	11.36	5.39	0.28	0.00	0.00	0.00	0.00	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	31.12	9.85	3.94	3.15	0.00	0.00	1.18	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	15.74	7.62	1.52	0.76	0.00	0.76	0.51	0.25	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	13.18	3.99	1.20	0.40	0.40	0.00	0.00	0.00	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	14.21	5.02	1.67	0.42	0.00	0.42	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	18.33	4.13	0.92	0.00	0.46	0.46	0.46	0.00	0.00
Synoviocyte, donor1	11291-117A4	23.40	4.21	2.52	1.35	0.17	0.34	0.50	0.17	0.00
Synoviocyte, donor2	11368-117I9	20.79	4.02	2.35	1.17	0.34	0.84	0.17	0.50	0.00
Synoviocyte, donor3	11440-118H9	16.98	6.70	2.68	2.68	0.89	0.45	0.45	0.67	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	9.65	7.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	5.95	7.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	9.03	3.47	0.00	0.00	0.46	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	13.62	5.16	0.29	0.50	0.65	0.00	0.07	0.07	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	8.50	6.19	0.39	0.00	0.00	0.00	0.00	0.00	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	9.74	2.86	0.00	0.00	0.57	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	68.89	13.90	4.67	1.23	2.46	0.74	0.37	0.12	0.12
Urethra, donor2	10319-105A4	71.94	14.39	1.80	5.40	3.60	1.80	1.80	1.80	0.00
Urothelial Cells, donor1	11520-119H8	3.98	0.27	0.00	0.27	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	4.81	1.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	3.90	3.44	0.46	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	14.71	7.58	1.56	0.89	0.45	0.45	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	91.65	18.69	3.56	0.00	0.89	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	87.21	15.73	2.86	2.86	5.72	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	43.12	8.90	2.74	2.05	1.37	0.68	0.68	0.68	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	82.99	18.59	4.48	1.38	2.07	0.34	0.00	0.00	1.72
Whole blood (ribopure), donor090325, donation2	12177-128I8	80.76	15.69	2.32	0.00	2.32	0.58	0.58	0.00	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	78.09	21.87	3.12	3.12	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	71.59	19.27	1.84	3.67	0.00	0.00	0.00	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	44.73	5.48	5.48	0.91	1.83	0.00	0.00	0.00	0.91
Wilms' tumor cell line:G-401	10809-111A8	41.82	11.35	3.45	0.86	1.11	0.37	0.74	0.49	0.00
Wilms' tumor cell line:HFWT	10597-108E3	52.80	15.84	1.76	1.76	0.88	2.64	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	27.37	11.45	2.51	2.23	0.28	1.40	0.28	0.28	0.28
achilles tendon, donor2	10292-104G4	64.06	6.20	0.00	4.13	2.07	0.00	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	71.90	17.59	26.01	11.98	2.55	3.57	2.55	2.04	0.76
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	96.82	16.95	5.80	3.25	3.02	0.93	1.16	0.46	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	174.38	34.19	11.87	6.53	4.51	1.19	1.19	0.95	1.07
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	97.42	16.05	34.56	15.51	1.90	2.18	1.36	2.99	1.09
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	50.03	15.74	13.49	6.18	1.69	3.65	1.97	1.97	1.12
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	59.21	8.04	1.27	0.42	1.48	0.21	0.00	0.21	1.69
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	66.69	14.43	5.17	9.26	1.91	1.09	1.36	1.09	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	65.66	14.98	8.81	5.73	2.64	0.88	0.88	0.00	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	78.00	8.58	11.03	6.53	2.45	2.04	2.86	1.23	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	85.43	15.53	11.65	5.82	2.72	1.16	1.55	1.55	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	49.13	11.78	9.02	6.44	1.47	2.21	1.47	2.02	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	113.11	19.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	82.73	10.22	14.87	7.90	1.39	2.79	2.32	1.63	1.16
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	83.88	22.27	10.87	5.70	2.59	2.59	3.62	3.11	1.04
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	68.97	13.74	20.16	14.61	2.63	2.05	4.09	1.75	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	64.14	13.94	2.79	0.93	0.93	0.93	0.46	0.00	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	71.15	9.87	6.17	1.65	0.41	1.23	2.06	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	36.53	7.98	0.31	0.92	1.23	0.00	0.61	0.31	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	65.71	8.11	5.12	2.13	1.71	1.71	0.85	0.43	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	73.09	7.89	4.25	1.21	2.43	0.00	0.61	0.00	1.52
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	78.47	13.00	3.85	1.44	1.20	0.48	0.48	0.00	0.96
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	64.82	14.26	7.35	5.35	1.34	2.00	1.11	0.89	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	60.71	22.01	4.34	4.34	2.00	0.33	1.67	0.67	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	156.09	22.30	1.86	9.29	1.86	0.00	0.00	0.00	3.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	57.25	21.47	9.04	3.39	1.88	2.26	1.13	0.38	4.90
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	64.55	14.83	1.31	1.31	1.31	1.31	0.44	0.44	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	35.61	7.50	1.87	0.00	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	63.11	10.13	4.95	1.18	1.65	0.47	0.24	0.24	0.71
adipose tissue, adult, pool1	10010-101C1	50.88	14.58	3.10	1.24	0.93	0.16	0.16	0.00	0.00
adipose, donor1	10184-103D4	93.83	39.29	20.52	3.52	1.17	2.35	1.76	1.17	0.59
adipose, donor2	10185-103D5	17.44	10.95	1.22	1.22	0.00	0.00	0.00	0.00	0.00
adipose, donor3	10186-103D6	42.48	14.70	5.72	3.81	0.27	1.09	1.63	0.82	0.00
adipose, donor4	10187-103D7	73.67	32.94	20.80	6.07	1.73	2.60	1.73	5.20	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	50.19	17.36	2.68	0.63	1.42	0.16	0.79	0.16	0.16
adrenal gland, adult, pool1	10081-102A9	7.28	7.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	34.29	24.95	2.80	1.87	3.20	0.27	0.40	0.80	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	46.45	8.22	5.36	4.29	2.14	1.43	2.50	0.71	0.36
amniotic membrane cells, donor1	12235-129G3	36.17	15.53	1.16	0.23	2.09	0.70	0.46	0.70	0.23
amniotic membrane cells, donor2	12236-129G4	25.36	13.86	1.35	0.34	1.35	0.00	0.00	0.68	0.00
amniotic membrane cells, donor3	12237-129G5	23.27	12.37	3.54	1.18	1.77	0.00	0.59	0.00	0.00
amygdala - adult, donor10196	10167-103B5	60.48	18.97	1.19	5.93	1.19	2.37	3.56	0.00	0.00
amygdala, adult, donor10252	10151-102I7	55.76	12.57	10.34	5.47	3.24	0.61	1.01	1.01	0.81
amygdala, newborn, donor10223	10360-105E9	35.18	9.36	2.58	1.61	0.65	0.65	0.00	0.65	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	45.07	16.04	3.82	1.91	1.66	0.25	0.38	0.00	0.38
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	48.10	15.00	7.72	4.63	0.88	0.88	1.10	0.66	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	94.53	14.36	8.68	7.35	1.67	0.33	0.67	0.67	0.00
aorta, adult, pool1	10052-101G7	21.57	8.43	1.18	0.59	0.20	0.39	0.00	0.20	0.00
appendix, adult	10189-103D9	79.18	15.91	1.94	0.00	3.49	0.39	0.39	0.00	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	56.41	12.38	8.94	6.88	2.06	1.03	1.72	0.69	0.34
artery, adult	10190-103E1	48.91	6.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	80.40	18.69	4.93	1.45	1.16	0.43	0.00	0.58	0.29
b cell line:RPMI1788	10427-106D4	51.75	24.54	7.14	3.42	1.34	1.49	0.59	0.00	0.74
basal cell carcinoma cell line:TE 354.T	10702-109G9	20.53	12.21	1.66	1.11	0.00	0.55	0.55	0.00	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	46.64	9.92	1.39	1.19	1.39	0.60	0.10	0.40	0.69
bile duct carcinoma cell line:TFK-1	10496-107C1	150.14	25.94	16.57	7.36	2.85	1.17	1.51	1.34	0.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	38.03	4.47	2.80	2.24	1.12	1.68	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	45.30	17.82	1.20	1.09	2.93	0.33	0.22	0.43	0.33
blood, adult, pool1	10053-101G8	31.00	17.72	2.21	0.00	0.00	0.00	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	43.67	12.85	0.86	0.00	2.57	0.00	0.86	0.00	0.86
bone marrow, adult	10192-103E3	80.30	17.55	19.57	14.85	0.67	2.02	2.70	2.02	0.00
brain, adult, donor1	10084-102B3	15.38	1.03	0.00	0.00	1.03	1.03	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	40.31	8.69	3.12	1.22	1.56	0.45	0.56	0.22	0.33
brain, fetal, pool1	10085-102B4	8.01	0.00	0.00	0.00	2.67	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	47.57	10.24	2.31	2.64	1.65	0.99	1.32	0.66	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	179.37	44.44	5.12	3.00	6.37	0.50	0.37	1.12	2.37
breast, adult, donor1	10080-102A8	45.46	13.89	0.00	0.00	1.26	0.00	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	42.18	5.21	5.08	4.45	2.16	1.40	0.51	1.02	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	67.72	13.61	5.57	3.09	1.24	0.93	0.93	0.62	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	35.91	12.20	3.45	2.30	1.84	0.00	0.23	0.69	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	35.83	15.98	9.44	4.36	1.45	1.45	0.48	0.97	0.00
carcinoid cell line:NCI-H1770	10703-109H1	39.02	21.16	1.41	2.35	0.94	0.94	0.00	0.94	0.00
carcinoid cell line:NCI-H727	10735-110B6	57.10	20.02	2.08	1.53	2.41	0.55	0.22	0.11	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	27.57	16.48	2.85	1.58	1.90	0.95	0.32	0.32	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	59.36	19.43	16.24	9.58	1.60	3.46	3.19	0.80	0.80
caudate nucleus - adult, donor10196	10177-103C6	79.44	23.03	5.76	1.15	1.15	0.00	1.15	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	52.54	10.54	9.04	5.19	1.51	0.67	0.84	1.84	0.67
caudate nucleus, adult, donor10258	10379-105H1	54.25	14.52	9.93	0.76	0.00	2.29	3.06	0.00	0.76
caudate nucleus, newborn, donor10223	10354-105E3	45.78	11.35	3.66	1.46	2.56	0.00	0.37	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	148.58	46.61	11.65	0.00	2.91	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	86.47	34.16	14.73	10.46	5.34	1.07	2.35	1.28	0.21
cerebellum, adult, pool1	10083-102B2	39.32	14.49	7.59	6.90	2.07	1.03	0.69	1.38	0.00
cerebellum, newborn, donor10223	10357-105E6	152.77	30.72	9.96	6.64	0.83	0.83	1.66	0.83	0.00
cerebral meninges, adult	10188-103D8	42.11	14.62	1.76	0.76	0.50	0.25	0.76	0.00	0.00
cerebrospinal fluid, donor2	10294-104G6	40.20	11.69	3.65	1.46	1.46	0.73	0.00	1.46	0.00
cervical cancer cell line:D98-AH2	10552-107I3	87.28	14.81	5.90	2.01	2.01	0.58	0.29	0.29	0.72
cervical cancer cell line:ME-180	10553-107I4	60.32	13.92	2.82	1.33	1.66	0.50	0.17	0.66	0.33
cervix, adult, pool1	10013-101C4	70.45	19.63	5.04	1.05	1.36	0.31	0.42	0.31	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	47.79	10.31	0.70	0.70	2.23	0.28	0.28	0.14	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	16.98	5.23	0.00	1.31	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	73.45	23.36	9.32	3.36	1.74	1.12	0.75	0.50	0.00
choriocarcinoma cell line:SCH	10785-110H2	41.89	11.71	5.54	3.20	0.86	0.62	1.36	0.49	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	46.25	16.37	4.27	0.47	0.71	0.71	0.24	0.24	0.24
chorionic membrane cells, donor1	12238-129G6	33.62	10.26	1.71	0.00	0.57	0.28	0.00	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	29.63	11.43	1.09	0.70	0.80	0.20	0.00	0.10	0.20
chorionic membrane cells, donor3	12240-129G8	32.97	11.54	3.85	1.65	1.65	0.00	0.00	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	42.41	11.11	5.05	2.02	0.00	2.02	1.01	0.00	3.03
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	58.78	8.45	3.07	0.58	1.34	0.77	0.77	0.19	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	49.21	5.70	3.38	1.06	0.63	0.42	0.21	0.00	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	51.10	24.65	4.62	0.77	1.03	0.77	1.28	0.77	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	55.87	26.12	3.39	2.90	0.97	0.73	0.97	0.48	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	67.60	29.32	4.48	4.68	1.22	0.81	1.22	1.22	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	70.08	19.14	10.31	6.77	2.65	0.59	0.88	0.29	1.18
chronic myelogenous leukemia cell line:KU812	10409-106B4	129.53	23.72	7.04	1.56	3.65	0.78	0.00	1.30	3.39
clear cell carcinoma cell line:JHOC-5	10638-108I8	26.74	7.77	5.26	1.60	1.14	0.46	1.14	0.91	0.00
clear cell carcinoma cell line:TEN	10636-108I6	67.32	11.97	3.30	2.60	1.56	0.52	0.35	0.35	0.17
colon carcinoma cell line:CACO-2	10513-107D9	45.39	6.59	1.46	1.10	1.65	0.18	0.18	0.18	0.00
colon carcinoma cell line:COLO-320	10420-106C6	112.12	32.31	6.84	3.80	1.52	0.76	0.38	1.52	0.00
colon, adult, donor1	10082-102B1	42.84	9.52	0.00	1.19	0.00	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	56.28	14.92	0.82	0.47	2.47	0.00	0.00	0.12	0.47
colon, fetal, donor1	10070-101I7	40.17	9.89	1.85	0.62	1.85	0.62	0.62	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	330.01	41.25	0.00	0.00	4.58	0.00	0.00	0.00	4.58
common myeloid progenitor CMP, donor2	12134-128E1	100.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	243.06	41.64	7.65	3.40	6.80	0.42	0.00	0.85	1.27
cord blood derived cell line:COBL-a 24h infection	10453-106G3	108.07	9.21	2.41	2.11	1.51	0.30	0.60	0.45	0.45
cord blood derived cell line:COBL-a untreated	10449-106F8	109.28	11.42	4.37	3.10	1.97	0.28	0.71	0.99	0.14
corpus callosum, adult, pool1	10042-101F6	66.67	16.14	2.65	1.77	1.88	0.33	0.00	0.22	0.11
cruciate ligament, donor2	10295-104G7	96.45	16.21	2.43	3.24	0.81	0.00	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	36.92	5.62	1.61	2.41	0.80	0.00	0.00	0.00	0.00
diencephalon, adult	10193-103E4	42.00	9.84	4.08	4.08	0.00	0.48	0.72	1.44	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	63.37	20.21	18.14	11.48	0.23	5.28	3.67	2.53	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	101.29	25.39	3.33	2.56	2.82	0.51	0.77	0.51	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	32.50	13.24	7.70	2.65	0.48	0.72	0.00	0.24	0.00
ductus deferens, adult	10196-103E7	50.33	14.45	1.99	4.49	2.99	1.00	1.99	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	66.25	11.52	7.20	1.44	0.00	1.44	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	86.81	23.54	11.03	8.09	0.00	2.94	2.21	0.00	0.00
dura mater, adult, donor1	10041-101F5	44.10	17.01	0.58	0.66	0.66	0.25	0.08	0.08	1.07
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	66.18	36.20	1.11	1.11	1.78	0.89	0.44	0.00	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	34.82	14.47	2.29	0.72	0.43	0.00	0.29	0.14	0.57
embryonic pancreas cell line:1B2C6	10604-108F1	51.18	14.18	2.47	1.85	0.62	1.23	0.00	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	29.67	14.23	2.12	0.30	1.21	0.30	0.00	0.30	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	61.44	26.55	2.16	1.54	0.93	0.31	0.00	0.00	0.31
embryonic pancreas cell line:2C6	10603-108E9	32.84	15.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	48.60	16.42	2.35	1.01	1.01	0.34	0.34	1.01	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	72.86	8.34	17.22	8.70	0.91	2.54	1.63	1.81	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	30.23	13.19	6.27	3.38	0.96	2.25	1.45	0.64	0.00
epidermoid carcinoma cell line:A431	10426-106D3	99.49	26.12	3.33	0.89	2.89	0.78	0.33	0.22	0.44
epidermoid carcinoma cell line:Ca Ski	10431-106D8	57.52	17.93	3.52	3.41	2.86	1.32	0.66	0.33	0.22
epididymis, adult	10197-103E8	49.19	11.09	1.26	1.05	1.05	0.84	0.21	1.05	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	42.40	12.60	13.84	6.03	2.13	1.24	0.53	1.24	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	33.43	9.83	1.18	0.39	1.57	1.18	0.39	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	76.53	13.63	10.09	6.29	2.23	0.79	1.83	2.36	1.05
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	85.33	15.75	11.71	7.48	1.77	0.98	1.97	1.67	2.17
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	73.04	14.45	10.19	5.49	2.46	1.57	1.23	0.78	2.13
esophagus, adult, pool1	10015-101C6	39.18	12.53	1.38	0.53	1.27	0.64	0.32	0.11	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	101.19	33.19	3.13	1.25	2.76	0.38	0.25	0.75	2.00
eye - muscle inferior rectus, donor1	10272-104E2	82.10	24.15	4.83	4.83	2.41	0.00	4.83	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	65.23	14.73	2.10	4.21	2.10	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	66.97	11.91	2.98	4.46	0.00	1.49	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	68.79	10.32	4.59	1.15	1.15	1.15	0.00	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	51.01	8.74	1.46	4.37	0.00	0.00	0.00	1.46	0.00
eye, fetal, donor1	10054-101G9	30.76	9.92	4.07	2.54	1.27	0.25	0.76	0.76	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	30.26	8.59	3.33	3.33	0.77	0.90	0.26	0.38	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	30.86	14.72	4.04	2.14	0.47	0.47	0.71	0.95	0.00
frontal lobe, adult, pool1	10040-101F4	68.68	14.26	3.28	2.44	1.88	0.66	0.38	0.47	0.66
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	98.18	18.92	28.22	12.61	2.40	3.00	2.10	0.90	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	44.53	18.29	1.19	0.82	3.38	0.18	0.27	0.09	0.00
gall bladder, adult	10198-103E9	44.91	12.07	0.72	0.72	0.97	0.48	0.24	0.48	0.97
gamma delta positive T cells, donor1	11937-126A2	114.35	31.67	2.15	1.07	2.15	1.07	0.00	0.00	3.76
gamma delta positive T cells, donor2	11938-126A3	112.79	23.16	1.49	1.12	4.11	0.37	0.00	0.75	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	29.36	12.67	8.45	5.07	1.48	2.75	0.84	1.06	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	51.84	16.25	10.06	5.22	1.93	2.13	0.77	1.16	0.00
gastric cancer cell line:AZ521	10549-107H9	78.04	14.43	4.75	1.48	3.77	0.98	0.49	0.49	0.33
gastric cancer cell line:GSS	10560-108A2	56.74	17.39	4.58	1.83	0.92	0.92	0.92	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	61.00	8.91	14.85	6.85	1.83	1.37	1.37	1.14	0.00
giant cell carcinoma cell line:LU65	10487-107B1	30.06	14.92	6.08	3.10	1.49	0.34	0.34	0.57	0.34
giant cell carcinoma cell line:Lu99B	10433-106E1	41.71	23.51	1.96	1.40	2.66	0.28	0.70	0.28	0.42
glassy cell carcinoma cell line:HOKUG	10688-109F4	100.02	14.72	7.98	3.49	1.25	1.75	0.75	2.00	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	48.45	15.31	2.74	2.11	1.69	0.63	0.21	0.63	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	48.45	14.75	5.34	2.81	2.11	1.12	0.14	0.28	0.00
glioblastoma cell line:T98G	10485-107A8	35.21	11.26	3.42	2.87	1.55	0.22	0.55	0.11	0.00
glioma cell line:GI-1	10413-106B8	45.98	8.79	0.88	0.00	1.46	0.88	0.00	0.00	0.29
globus pallidus - adult, donor10196	10175-103C4	80.91	25.51	2.92	2.19	0.73	1.46	0.73	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	76.16	21.97	8.30	8.30	5.86	0.49	0.98	2.44	0.73
globus pallidus, adult, donor10258	10367-105F7	69.83	21.91	4.11	6.85	0.00	2.74	1.37	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	47.43	11.72	1.07	0.53	1.07	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	266.74	34.26	0.00	0.00	12.24	2.45	0.00	0.00	7.34
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	10.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	36.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	28.16	7.36	3.20	0.96	0.64	0.32	0.64	0.00	0.32
hIPS +CCl2, biol_rep1	14383-156B9	86.31	27.55	6.43	7.35	0.46	2.75	0.00	0.46	0.46
hIPS +CCl2, biol_rep2	14384-156C1	92.37	38.41	10.06	6.86	0.46	0.91	1.37	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	83.09	25.76	8.37	7.73	0.00	1.93	1.29	0.64	0.00
hIPS, biol_rep1	14380-156B6	132.23	68.99	8.62	2.87	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	78.87	37.72	6.17	4.12	2.06	4.80	2.06	0.00	0.00
hIPS, biol_rep3	14382-156B8	47.45	19.86	5.52	2.21	0.00	0.00	2.21	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	37.93	11.21	6.32	5.75	1.44	2.30	1.44	2.01	1.15
heart - mitral valve, adult	10205-103F7	69.36	17.64	0.90	2.39	1.79	0.00	0.30	0.60	0.00
heart - pulmonic valve, adult	10206-103F8	65.89	15.69	7.58	6.80	1.31	1.05	2.09	0.52	0.26
heart - tricuspid valve, adult	10207-103F9	82.43	14.99	2.50	2.50	2.50	0.83	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	23.26	9.59	4.08	1.63	0.41	1.02	1.02	1.02	0.00
heart, adult, diseased, donor1	10051-101G6	20.44	12.35	0.00	0.00	0.00	0.43	0.00	0.00	0.00
heart, adult, pool1	10016-101C7	36.34	16.33	0.69	0.00	1.84	0.00	0.00	0.00	0.23
heart, fetal, pool1	10046-101G1	70.34	16.22	1.85	1.03	1.64	0.41	0.10	0.41	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	16.97	7.40	0.62	0.00	0.31	0.31	0.00	0.31	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	49.95	13.08	1.19	2.38	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	55.25	11.93	6.52	2.32	2.21	0.88	1.22	0.88	0.33
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	53.77	11.17	4.73	2.06	1.70	1.09	1.09	1.58	0.49
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	60.63	14.45	5.05	3.74	1.92	1.11	1.41	1.31	0.30
hepatoma cell line:Li-7	10484-107A7	81.41	25.13	10.23	6.56	1.22	0.67	0.33	0.78	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	43.72	15.28	2.81	2.21	2.31	1.01	0.50	0.30	0.10
hippocampus - adult, donor10196	10169-103B7	44.48	12.30	9.46	4.73	1.89	0.00	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	60.01	17.35	10.20	7.76	1.84	1.63	1.02	1.84	0.82
hippocampus, adult, donor10258	10374-105G5	57.76	21.91	6.97	5.98	0.00	1.99	1.49	0.00	0.50
hippocampus, newborn, donor10223	10363-105F3	32.43	7.40	1.06	0.70	0.35	0.00	0.00	0.35	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	123.29	57.98	5.49	2.44	2.44	3.05	1.22	0.61	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	63.82	24.54	11.58	4.32	2.16	1.18	1.37	1.77	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	77.44	34.02	7.87	2.54	2.29	0.76	1.27	0.51	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	37.22	12.97	1.69	0.00	1.13	0.56	2.26	0.00	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	38.73	17.30	7.49	2.32	0.77	3.87	0.77	1.03	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	44.03	14.05	3.42	1.90	0.76	1.14	0.38	0.38	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	55.47	18.10	2.04	1.46	0.88	1.17	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	45.46	11.85	4.31	1.29	1.72	1.29	0.65	0.43	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	55.47	12.10	0.83	0.00	1.25	0.42	0.42	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	57.07	15.87	1.66	0.95	0.47	0.24	0.00	0.00	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	46.29	9.80	3.86	1.61	1.13	1.29	0.16	0.64	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	50.50	17.51	0.67	0.67	0.67	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	58.53	24.72	8.76	4.54	2.19	2.66	1.41	0.94	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	70.26	36.36	15.72	6.88	2.46	5.40	1.97	1.47	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	126.55	34.04	12.22	3.49	2.62	2.62	5.24	1.75	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	41.81	15.27	3.63	3.05	1.34	1.15	0.38	0.38	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	32.71	16.13	3.49	2.18	1.74	1.74	0.44	1.74	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	53.97	19.99	0.50	1.00	0.50	0.00	1.50	0.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	15.82	9.61	1.51	1.51	0.38	0.19	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	30.01	10.91	4.55	1.36	0.91	0.00	0.45	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	26.31	12.53	1.88	0.94	0.94	0.31	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	33.15	8.49	2.29	0.16	0.98	0.65	0.00	0.49	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	30.48	8.13	1.74	1.16	1.16	0.29	0.29	0.29	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	32.28	8.07	2.39	0.90	0.90	0.30	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	63.55	22.17	10.35	6.10	1.85	1.66	1.66	0.55	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	58.48	23.11	8.27	2.57	1.43	1.14	0.29	0.86	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	87.38	41.24	9.80	3.27	3.27	1.63	1.22	0.41	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	36.26	14.08	5.63	1.06	0.35	1.06	0.70	0.00	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	23.12	14.25	4.75	2.53	1.27	0.95	0.00	0.32	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	28.14	13.32	1.21	0.61	0.91	0.61	0.30	0.30	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	32.58	10.86	2.07	0.00	0.00	0.52	0.52	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	33.87	13.28	0.00	0.66	1.33	0.00	0.00	1.33	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	35.40	11.29	1.03	0.26	1.28	0.51	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	38.35	10.99	2.81	1.79	1.02	0.51	0.00	0.00	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	46.19	15.90	2.27	2.27	0.00	1.51	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	38.31	7.06	1.34	0.67	0.67	0.34	0.00	0.00	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	64.97	30.67	9.18	3.38	2.90	1.21	0.72	0.48	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	92.25	25.85	8.47	3.57	3.12	0.89	1.34	1.34	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	78.54	21.46	4.39	2.44	3.41	0.49	0.00	0.49	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	31.78	12.84	6.72	2.44	0.31	0.31	0.31	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	266.77	71.57	26.03	13.01	6.51	6.51	13.01	3.25	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	45.34	13.90	3.31	1.65	1.32	0.66	0.33	0.99	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	37.76	14.23	2.74	2.19	1.09	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	32.93	13.39	3.26	1.09	1.09	0.72	0.36	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	31.32	16.37	0.71	0.71	0.36	0.71	0.00	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	39.38	7.16	3.58	3.58	3.58	0.00	0.00	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	53.36	14.22	0.81	0.27	1.08	0.68	0.00	0.27	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	32.87	6.73	1.62	0.27	0.54	0.00	0.00	0.00	0.27
immature langerhans cells, donor1	11904-125F5	99.52	19.37	1.21	0.24	0.73	0.24	0.24	0.00	0.48
immature langerhans cells, donor2	11905-125F6	79.21	12.67	0.79	0.00	0.79	0.79	0.00	0.00	0.79
insula, adult, pool1	10039-101F3	45.61	9.46	0.76	1.04	1.04	0.09	0.09	0.00	0.47
keratoacanthoma cell line:HKA-1	10791-110H8	30.24	6.50	1.30	0.98	0.65	0.00	0.00	0.33	0.00
kidney, adult, pool1	10017-101C8	50.76	13.92	5.51	2.40	2.20	1.40	0.40	0.10	0.30
kidney, fetal, pool1	10045-101F9	49.52	11.67	0.57	0.28	1.70	0.14	0.07	0.07	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	60.36	24.14	1.42	0.57	2.70	0.43	0.00	0.28	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	20.87	7.88	1.52	0.41	0.41	0.14	0.28	0.41	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	43.67	12.11	1.83	0.37	2.20	0.18	0.37	0.37	0.00
left atrium, adult, donor1	10079-102A7	18.52	10.35	1.63	0.54	0.54	0.54	0.54	0.00	0.00
left ventricle, adult, donor1	10078-102A6	24.27	8.09	2.02	1.01	0.00	0.00	0.51	1.01	0.00
leiomyoblastoma cell line:G-402	10721-110A1	44.87	14.23	2.19	0.55	1.64	0.27	0.27	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	8.26	0.36	0.36	0.00	0.00	0.36	0.00	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	7.61	2.17	1.63	0.00	0.00	0.00	0.54	0.00	0.54
leiomyoma cell line:15425	10571-108B4	12.38	5.34	2.19	0.97	0.73	0.73	0.24	0.00	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	6.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	29.28	8.36	1.05	3.14	0.00	2.09	0.00	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	64.11	15.82	8.62	5.43	1.89	1.18	0.71	0.83	0.83
liposarcoma cell line:KMLS-1	10782-110G8	25.93	5.62	2.03	0.31	0.94	0.00	0.47	0.00	0.00
liposarcoma cell line:SW 872	10726-110A6	38.50	9.50	2.07	0.97	0.97	0.24	0.24	0.24	0.12
liver, adult, pool1	10018-101C9	31.12	9.08	1.13	1.13	0.65	0.32	0.16	0.00	0.16
liver, fetal, pool1	10086-102B5	15.05	8.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	71.16	25.08	7.58	4.96	2.04	1.17	0.58	0.73	0.15
locus coeruleus, adult, donor10252	10165-103B3	48.91	20.85	8.12	6.83	2.95	1.29	1.66	1.29	0.18
locus coeruleus, adult, donor10258	10375-105G6	31.88	11.00	1.97	1.13	1.97	0.28	1.41	0.28	0.56
locus coeruleus, newborn, donor10223	10362-105F2	71.51	22.71	7.57	6.31	0.84	0.42	1.68	0.42	0.84
lung adenocarcinoma cell line:A549	10499-107C4	56.60	13.70	0.55	0.00	0.97	0.14	0.28	0.14	0.55
lung adenocarcinoma cell line:PC-14	10408-106B3	62.74	21.37	0.69	0.00	4.14	0.00	0.00	0.00	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	42.97	23.99	0.40	0.79	0.92	0.26	0.26	0.00	0.40
lung, adult, pool1	10019-101D1	30.36	13.47	1.30	0.47	0.59	0.24	0.00	0.12	0.12
lung, fetal, donor1	10068-101I5	129.86	37.67	1.14	2.28	2.00	0.57	0.57	0.00	0.00
lung, right lower lobe, adult, donor1	10075-102A3	37.57	14.20	3.21	3.67	0.46	2.29	0.46	1.37	0.46
lymph node, adult, donor1	10077-102A5	30.77	10.41	3.31	2.37	0.47	1.42	1.42	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	28.27	16.88	2.85	2.63	1.97	0.44	0.44	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	86.03	10.72	2.57	2.41	1.51	0.30	0.30	1.06	0.30
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	231.91	31.43	4.25	0.85	6.80	0.00	1.70	0.85	0.85
mature adipocyte, donor1	12231-129F8	88.35	51.06	0.00	0.00	3.55	0.00	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	62.88	36.94	0.42	0.42	3.53	0.21	0.00	0.21	0.21
mature adipocyte, donor3	12233-129G1	78.70	41.72	0.00	0.24	4.03	0.00	0.00	0.24	0.24
mature adipocyte, donor4	12234-129G2	119.76	54.75	0.26	0.53	4.21	0.00	0.00	0.26	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	105.55	30.26	1.67	1.43	4.29	0.24	0.00	0.24	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	63.17	12.41	5.64	12.41	1.13	1.13	1.13	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	54.62	11.59	9.20	6.07	2.39	1.47	0.55	1.47	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	39.71	11.75	6.35	4.13	1.27	0.64	1.59	0.64	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	83.17	14.07	3.84	2.56	1.71	0.85	0.00	0.85	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	64.97	19.74	8.94	5.40	1.86	3.88	2.19	2.70	0.84
medial temporal gyrus, adult, donor10252	10156-103A3	62.61	17.61	11.88	9.13	3.61	1.70	2.55	1.27	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	92.46	19.26	1.93	3.85	0.00	1.93	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	918.63	215.30	43.06	100.48	28.71	28.71	14.35	28.71	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	38.05	8.61	1.08	1.79	0.72	0.36	0.00	0.36	1.08
medulla oblongata - adult, donor10196	10174-103C3	52.57	20.77	1.30	3.24	0.65	0.00	0.65	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	61.15	21.98	9.13	7.89	2.94	0.93	1.39	0.62	0.31
medulla oblongata, adult, pool1	10038-101F2	35.02	11.43	0.24	0.49	1.06	0.24	0.08	0.00	0.16
medulla oblongata, newborn, donor10223	10361-105F1	51.04	10.42	2.43	2.78	1.04	0.35	0.00	0.00	0.35
medulloblastoma cell line:D283 Med	10838-111E1	78.38	42.51	14.83	16.16	2.66	4.65	3.54	2.44	0.22
medulloblastoma cell line:ONS-76	10759-110E3	25.92	13.08	3.06	1.22	1.10	0.12	0.12	0.12	0.12
melanoma cell line:COLO 679	10514-107E1	27.60	4.46	1.29	1.01	0.57	0.00	0.00	0.29	0.14
melanoma cell line:G-361	10465-106H6	37.73	13.84	10.32	5.70	1.63	1.09	1.09	1.09	0.54
meningioma cell line:HKBMM	10691-109F7	14.83	9.59	2.53	1.09	0.36	0.72	0.18	0.18	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	96.05	23.79	4.41	4.41	1.76	1.76	3.52	0.88	2.64
merkel cell carcinoma cell line:MS-1	10844-111E7	74.92	22.55	3.37	2.33	1.30	0.52	0.52	0.26	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	26.08	7.52	2.61	1.38	1.07	0.15	0.31	0.15	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	22.54	8.73	1.82	0.91	1.09	0.55	0.18	0.00	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	33.13	7.87	2.90	1.24	0.41	0.00	0.41	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	17.98	6.74	1.40	1.12	0.28	0.42	0.00	0.56	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	20.80	6.55	2.12	0.96	0.96	0.77	0.19	0.00	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	19.43	7.63	0.00	1.39	0.00	0.69	0.00	0.00	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	13.90	10.47	1.20	0.69	0.69	0.17	0.69	0.17	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	22.08	7.94	1.04	1.04	0.35	0.35	0.23	0.12	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	23.34	7.03	1.33	0.66	0.80	0.53	0.27	0.00	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	22.42	7.83	2.70	1.22	0.68	0.00	0.27	0.14	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	25.04	8.82	3.41	1.56	0.57	0.57	0.57	0.43	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	22.40	7.25	1.98	0.99	0.66	0.33	0.66	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	22.69	8.03	2.08	0.55	0.42	0.14	0.14	0.14	0.55
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	26.53	8.38	3.84	1.75	1.40	1.40	1.05	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	14.70	5.92	0.82	1.02	0.41	0.00	0.41	0.20	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	19.05	5.75	2.16	2.52	0.00	0.00	0.72	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	14.90	6.93	1.14	0.83	0.41	0.00	0.00	0.10	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	16.19	7.30	1.37	2.28	0.23	0.46	0.46	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	35.66	15.10	4.62	0.84	1.26	0.84	0.84	0.42	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	17.93	8.52	1.34	0.75	0.75	0.60	0.15	0.00	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	22.58	9.02	2.28	1.75	0.88	0.09	0.35	0.18	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	29.45	9.94	0.00	0.37	0.74	0.00	0.37	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	24.32	11.45	3.72	2.58	0.57	0.29	0.29	0.00	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	35.37	11.37	2.11	3.37	0.84	2.11	0.42	0.42	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	18.27	4.57	1.83	0.00	0.00	0.00	0.00	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	20.21	3.58	1.02	0.77	0.51	0.26	0.26	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	21.73	6.02	0.52	0.26	0.26	0.26	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	21.57	7.70	2.46	1.54	0.00	0.62	0.31	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	18.59	4.47	0.94	1.18	0.00	0.24	0.71	0.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	22.34	5.08	1.35	1.02	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	22.01	5.11	1.96	1.18	0.79	0.00	0.79	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	22.71	5.10	2.32	0.93	0.46	0.00	0.93	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	29.13	7.21	1.15	1.15	0.29	0.00	0.00	0.58	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	21.64	4.24	1.12	0.67	0.67	0.22	0.67	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	18.99	6.01	1.20	0.24	0.48	0.24	0.24	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	30.80	8.07	0.00	0.00	1.47	0.00	0.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	19.47	2.69	0.00	1.01	0.67	0.67	0.34	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	20.47	2.05	1.23	0.82	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	19.33	5.15	2.15	0.00	0.00	0.43	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	24.61	0.00	0.00	0.00	2.73	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	10.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	21.76	7.15	0.32	0.32	0.00	0.65	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	27.64	8.73	0.00	0.00	0.00	0.00	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	18.12	11.73	0.00	0.53	0.53	0.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	22.90	9.00	2.45	1.64	0.82	0.00	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	19.44	7.00	0.78	0.39	0.39	0.78	0.00	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	23.09	4.20	0.00	4.20	0.00	0.00	0.00	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	21.86	8.94	1.99	0.99	0.00	0.00	0.00	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	4.77	0.00	0.00	4.77	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	23.72	5.93	0.00	0.00	0.59	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	25.59	2.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	25.34	9.50	0.63	0.00	0.00	0.63	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	26.21	6.90	1.72	0.69	0.34	0.00	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	17.19	2.15	0.00	0.00	2.15	4.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	7.98	0.00	0.00	0.00	0.00	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	17.22	6.89	0.00	3.44	3.44	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	12.63	4.48	2.85	0.81	0.81	1.22	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	17.48	2.38	3.97	2.38	0.00	0.00	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	13.56	1.77	4.13	1.18	1.18	0.59	0.00	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	19.64	6.86	1.87	1.25	0.31	0.31	0.31	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	10.69	5.35	4.01	0.00	1.34	1.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	29.57	8.28	13.01	2.37	1.18	1.18	2.37	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	30.82	7.70	12.84	2.57	0.00	0.00	2.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	33.04	9.64	11.01	4.82	1.38	0.69	1.38	2.07	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	34.14	15.83	15.34	4.95	1.98	1.98	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	23.55	21.31	11.22	1.12	0.00	2.24	0.00	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	27.99	24.17	15.90	9.54	1.27	2.54	3.18	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	19.75	13.70	2.42	2.01	0.40	0.00	0.00	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	4.36	6.54	4.36	2.18	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	11.40	10.14	0.00	1.27	0.00	1.27	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	26.10	16.39	1.82	1.21	0.61	0.61	0.61	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	22.59	22.59	9.04	0.00	4.52	4.52	9.04	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	23.89	16.47	7.41	8.24	2.47	0.82	3.29	0.82	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	32.15	11.31	0.20	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	28.56	11.03	2.60	1.95	1.95	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	18.34	10.19	6.11	3.06	0.00	1.02	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	35.59	7.74	0.00	0.00	0.77	0.00	0.00	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	38.98	29.29	1.18	0.24	1.42	0.24	0.24	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	54.67	18.30	3.24	2.55	2.55	0.70	0.00	0.70	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	34.19	8.55	0.00	0.00	0.00	4.27	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	35.35	7.19	2.57	1.85	0.62	0.10	0.72	0.51	0.21
mesothelioma cell line:Mero-25	10850-111F4	34.50	12.71	3.18	2.50	2.04	1.13	0.45	0.23	0.00
mesothelioma cell line:Mero-41	10851-111F5	27.14	10.27	3.42	1.71	1.22	1.22	0.24	0.00	0.24
mesothelioma cell line:Mero-48a	10852-111F6	25.02	6.64	2.66	1.99	0.66	0.22	0.66	0.66	0.00
mesothelioma cell line:Mero-82	10853-111F7	48.36	11.83	11.56	8.41	1.05	3.68	2.10	1.58	0.26
mesothelioma cell line:Mero-83	10854-111F8	42.38	10.89	4.94	4.09	0.85	0.51	1.02	0.51	0.00
mesothelioma cell line:Mero-84	10855-111F9	24.27	7.84	1.52	1.26	0.00	0.25	0.25	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	39.55	8.70	3.31	1.24	2.07	1.04	0.83	0.21	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	28.33	9.11	4.64	3.31	1.49	0.66	0.83	0.83	0.50
mesothelioma cell line:NCI-H226	10846-111E9	55.02	12.31	7.24	3.26	1.63	1.45	1.81	0.54	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	39.46	13.32	5.81	2.90	1.02	1.20	1.20	0.34	0.51
mesothelioma cell line:NCI-H28	10845-111E8	73.80	12.21	8.14	6.62	2.80	0.76	1.78	0.76	0.25
mesothelioma cell line:No36	10857-111G2	27.07	8.48	2.28	2.61	0.00	0.65	0.33	0.33	0.00
mesothelioma cell line:ONE58	10858-111G3	31.97	10.84	2.98	3.52	0.54	0.54	0.54	0.27	0.27
migratory langerhans cells, donor1	11901-125F2	36.47	16.51	1.34	0.38	1.15	0.38	0.58	0.19	0.00
migratory langerhans cells, donor2	11902-125F3	34.44	10.87	0.37	0.24	0.73	0.24	0.24	0.00	0.24
migratory langerhans cells, donor3	11903-125F4	45.59	22.97	2.51	1.08	0.72	0.18	0.18	0.18	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	29.06	19.26	5.88	6.53	2.29	1.96	1.31	1.31	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	23.31	6.15	2.12	0.21	0.85	0.42	0.21	0.42	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	43.08	18.89	3.69	2.07	0.92	0.23	0.69	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	35.77	8.94	2.28	1.90	0.57	0.38	1.14	0.00	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	87.04	13.49	4.07	2.40	3.51	0.55	0.55	0.55	1.29
myeloma cell line:PCM6	10474-106I6	49.81	20.36	10.87	7.31	1.38	0.79	0.99	0.79	4.15
myxofibrosarcoma cell line:MFH-ino	10600-108E6	38.55	10.65	1.01	0.51	0.00	0.00	0.00	0.00	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	55.12	8.63	4.51	3.14	0.98	0.98	0.98	0.39	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	15.82	19.50	0.11	0.22	1.00	0.00	0.00	0.22	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	17.58	18.46	0.51	0.22	1.25	0.15	0.00	0.00	0.22
nasal epithelial cells, donor2	12227-129F4	17.66	12.14	0.55	0.00	0.55	0.00	0.55	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	127.68	25.77	2.30	2.99	3.68	0.46	0.23	0.00	1.15
neuroblastoma cell line:NB-1	10539-107G8	69.41	26.38	4.49	2.43	2.62	0.75	0.37	0.00	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	61.79	14.55	6.33	3.37	1.27	1.05	1.05	0.84	0.00
neuroblastoma cell line:NH-12	10555-107I6	76.96	22.55	8.01	4.66	1.68	1.68	1.12	2.24	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	63.58	13.28	12.34	10.20	1.42	1.42	1.42	0.24	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	66.20	21.86	6.02	4.75	0.95	1.11	1.90	0.95	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	25.16	12.48	4.83	3.42	0.60	0.40	0.40	0.20	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	31.15	8.26	1.91	0.00	1.91	0.00	0.64	0.00	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	25.29	6.39	0.53	0.27	1.06	0.00	0.27	0.00	0.00
neutrophil PMN, donor1	12133-128D9	104.12	59.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	53.12	13.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	47.35	18.94	0.00	0.00	9.47	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	185.36	27.06	16.57	7.10	2.88	2.03	1.18	1.18	0.68
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	32.02	12.81	0.00	0.00	0.80	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	24.69	5.13	1.60	0.00	0.32	0.32	0.32	0.32	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	16.55	6.31	2.10	1.05	0.53	1.05	0.00	0.26	0.00
nucleus accumbens, adult, pool1	10037-101F1	57.93	9.56	2.16	1.31	1.12	0.47	0.28	0.28	0.84
occipital cortex - adult, donor10196	10172-103C1	92.72	35.03	2.06	2.06	0.00	0.00	2.06	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	81.31	17.71	8.59	5.90	2.95	0.54	0.81	1.07	0.00
occipital cortex, newborn, donor10223	10355-105E4	41.13	11.65	2.18	0.73	0.36	0.73	0.36	0.00	1.46
occipital lobe, adult, donor1	10076-102A4	48.28	11.55	0.26	0.52	0.26	0.52	0.00	0.52	0.26
occipital lobe, fetal, donor1	10073-102A1	79.38	28.75	3.43	5.15	2.57	0.00	1.72	0.00	0.00
occipital pole, adult, pool1	10036-101E9	23.89	6.39	0.39	0.16	1.02	0.00	0.08	0.00	0.32
olfactory region, adult	10195-103E6	53.49	14.71	14.52	9.93	0.57	2.10	1.53	0.38	0.38
optic nerve, donor1	10277-104E7	102.05	22.01	0.00	0.00	4.00	2.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	94.43	18.34	5.47	4.44	1.37	0.91	0.57	0.46	0.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	25.42	9.62	0.96	0.27	0.27	0.27	0.00	0.14	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	41.99	11.01	6.94	5.08	1.69	2.37	1.69	2.03	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	38.58	5.78	4.04	3.00	0.23	0.69	0.92	0.69	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	24.69	6.76	1.47	2.06	0.29	0.59	0.00	0.29	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	104.65	33.64	0.00	0.93	5.61	0.93	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	57.68	11.24	3.61	1.70	1.48	0.21	0.21	0.64	0.21
ovary, adult, pool1	10020-101D2	34.68	10.74	1.40	0.79	0.44	0.17	0.17	0.09	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	19.07	9.35	1.28	0.92	0.92	0.18	0.18	0.37	0.00
pancreas, adult, donor1	10049-101G4	22.58	8.47	0.94	0.00	0.00	0.00	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	34.66	7.55	5.31	2.24	0.84	0.00	0.56	0.28	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	29.98	10.39	8.86	3.92	1.19	3.07	2.21	1.19	0.51
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	65.07	26.82	3.31	1.49	1.82	0.66	0.33	0.33	0.17
paracentral gyrus, adult, pool1	10035-101E8	49.06	9.70	2.84	1.46	1.28	0.46	0.55	0.37	0.73
parietal cortex, adult, donor10258	10373-105G4	46.98	14.68	18.35	9.54	0.00	2.20	0.73	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	60.19	23.51	6.58	4.70	0.00	1.88	0.00	0.94	0.94
parietal lobe, adult, donor10252	10157-103A4	57.01	18.53	14.54	7.70	2.28	0.29	0.86	0.57	0.29
parietal lobe, adult, pool1	10034-101E7	44.76	8.81	1.59	0.79	1.67	0.18	0.00	0.26	0.26
parietal lobe, fetal, donor1	10072-101I9	97.95	33.94	5.82	6.79	2.91	0.00	0.00	1.94	0.97
parietal lobe, newborn, donor10223	10356-105E5	50.10	11.96	4.49	4.49	0.75	0.00	0.00	0.00	0.37
parotid gland, adult	10199-103F1	49.95	14.18	3.08	1.23	1.23	0.00	0.00	0.62	0.00
penis, adult	10200-103F2	58.55	10.74	9.13	4.83	2.15	2.69	1.61	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	67.12	19.90	8.74	5.58	1.86	0.56	0.37	1.12	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	34.97	10.34	5.39	3.06	0.87	1.75	0.73	0.58	0.29
pineal gland - adult, donor10196	10179-103C8	95.46	30.96	1.94	1.94	2.58	0.00	0.65	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	116.07	44.42	10.66	5.92	7.11	1.78	1.18	0.59	0.59
pineal gland, adult, donor10258	10377-105G8	63.96	23.20	5.64	4.39	1.88	1.25	1.25	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	62.73	47.55	4.05	7.08	1.01	1.01	1.01	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	117.79	66.19	17.20	7.30	7.82	1.56	0.00	1.04	0.00
pituitary gland, adult, donor10258	10378-105G9	70.65	36.60	16.17	10.21	0.00	1.70	0.85	1.70	3.40
placenta, adult, pool1	10021-101D3	68.48	12.15	2.15	1.40	1.94	0.32	0.00	0.22	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	37.61	18.54	3.84	3.18	1.06	0.40	0.79	0.53	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	28.48	9.03	0.31	0.47	0.31	0.00	0.16	0.00	0.00
pons, adult, pool1	10033-101E6	60.16	17.13	3.96	2.07	2.41	0.43	0.09	0.43	0.34
postcentral gyrus, adult, pool1	10032-101E5	32.34	7.06	0.78	0.35	0.78	0.26	0.00	0.00	0.26
promyelocytes/myelocytes PMC, donor1	12132-128D8	144.31	79.47	0.00	0.00	2.09	2.09	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	38.56	11.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	53.89	10.05	10.49	4.95	1.60	0.73	0.87	1.17	0.44
prostate cancer cell line:PC-3	10439-106E7	49.55	18.51	9.80	4.17	1.63	1.27	2.18	1.27	0.36
prostate, adult, pool1	10022-101D4	46.62	13.15	1.72	0.73	1.81	0.54	0.09	0.36	0.00
putamen, adult, donor10196	10176-103C5	65.39	17.00	9.44	6.37	0.71	1.18	2.12	1.18	1.42
putamen, adult, donor10252	10152-102I8	56.86	13.73	3.92	1.96	1.96	1.96	3.92	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	99.45	32.78	8.74	15.30	0.00	2.19	5.46	0.00	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	59.44	14.01	9.18	6.04	1.21	1.93	0.24	1.21	1.21
putamen, newborn, donor10223	10365-105F5	80.21	7.50	7.50	3.75	0.75	0.75	0.75	0.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	106.77	20.07	5.24	1.75	2.91	0.58	0.00	0.58	0.00
rectum, fetal, donor1	10067-101I4	94.59	19.47	5.56	4.17	0.00	0.00	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	58.94	10.81	2.54	2.12	1.06	0.64	0.64	0.21	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	27.75	15.33	4.97	2.07	2.07	0.83	0.83	0.41	0.00
retina, adult, pool1	10030-101E3	45.62	14.31	2.09	0.80	1.39	0.20	0.10	0.20	0.40
retinoblastoma cell line:Y79	10475-106I7	112.75	20.52	16.11	11.69	3.38	1.30	1.30	1.82	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	37.50	15.37	3.57	2.83	1.23	0.49	0.49	0.74	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	104.89	33.46	3.94	2.81	4.50	0.56	0.56	0.84	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	19.70	6.06	2.27	3.03	0.76	0.00	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	22.17	8.74	5.50	3.40	0.00	0.49	0.32	1.13	0.00
salivary acinar cells, donor2	11772-123I8	21.20	8.81	7.16	4.54	0.69	0.96	1.38	1.65	0.00
salivary acinar cells, donor3	11773-123I9	43.70	13.90	1.32	4.63	0.66	0.00	0.00	1.99	0.00
salivary gland, adult, pool1	10093-102C3	38.32	10.30	0.00	0.00	0.57	0.57	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	53.45	15.34	5.14	3.79	1.10	0.93	0.34	0.59	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	49.84	13.52	7.29	3.76	1.29	0.59	0.82	0.82	0.00
seminal vesicle, adult	10201-103F3	80.95	21.16	1.06	3.17	4.76	3.17	1.59	0.00	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	30.61	9.47	2.43	1.21	2.92	0.00	0.24	0.49	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	15.10	3.02	0.50	0.75	0.00	0.25	0.00	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	20.07	7.02	1.00	3.01	1.00	2.01	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	35.33	14.64	8.33	4.84	0.81	1.75	1.48	0.67	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	59.24	16.25	2.87	2.32	1.55	0.44	0.55	0.22	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	62.06	10.32	1.81	1.29	0.90	0.26	0.13	0.00	0.52
skeletal muscle - soleus muscle, donor1	10282-104F3	63.13	14.19	4.97	7.80	0.00	1.42	2.13	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	50.25	13.67	2.04	0.48	1.32	0.24	0.12	0.12	0.12
skeletal muscle, fetal, donor1	10066-101I3	14.07	4.02	2.01	0.00	0.00	0.00	0.00	1.01	0.00
skin, adult, donor1	10074-102A2	6.79	6.79	0.00	0.00	0.00	0.00	0.00	0.00	6.79
skin, fetal, donor1	10065-101I2	72.59	16.41	0.00	0.00	3.79	0.00	0.00	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	38.02	8.67	2.00	2.33	2.33	0.33	0.00	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	76.91	38.46	23.33	17.02	2.21	4.10	3.15	1.58	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	44.33	39.90	2.51	1.35	2.51	0.96	0.77	0.19	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	156.59	38.40	5.93	3.79	3.46	1.32	0.66	0.49	0.82
small cell lung carcinoma cell line:NCI-H82	10842-111E5	25.74	36.51	9.49	5.63	0.48	1.45	0.97	1.13	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	50.12	13.95	8.93	5.45	1.09	0.87	0.44	0.22	0.00
small intestine, adult, pool1	10024-101D6	67.13	14.09	3.58	1.67	1.19	1.07	0.36	0.12	0.24
small intestine, fetal, donor1	10064-101I1	30.47	11.30	11.06	3.93	0.74	1.72	1.97	0.74	1.72
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	41.54	19.49	8.72	5.64	4.62	1.54	1.54	1.54	0.00
smooth muscle, adult, pool1	10048-101G3	39.80	15.25	5.43	2.07	0.78	1.29	1.03	1.03	0.26
somatostatinoma cell line:QGP-1	10781-110G7	45.56	17.69	3.75	0.80	3.48	0.54	0.27	0.00	0.54
spinal cord - adult, donor10196	10181-103D1	66.99	27.30	8.03	3.21	2.06	2.06	0.92	1.15	0.00
spinal cord, adult, donor10252	10159-103A6	82.80	27.99	9.86	3.94	3.55	0.00	0.39	1.58	0.00
spinal cord, adult, donor10258	10369-105F9	83.71	20.06	11.76	6.92	0.00	2.08	1.38	1.38	0.69
spinal cord, fetal, donor1	10056-101H2	56.10	10.98	0.61	1.22	0.00	1.22	1.83	1.22	0.00
spinal cord, newborn, donor10223	10359-105E8	77.61	20.21	9.18	3.67	1.84	0.92	2.30	0.92	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	22.85	8.66	1.34	0.90	0.90	0.00	0.30	0.30	0.00
spleen, adult, pool1	10025-101D7	58.70	15.42	2.42	1.43	1.87	0.55	0.11	0.22	0.00
spleen, fetal, pool1	10044-101F8	43.38	9.85	0.40	0.40	1.83	0.32	0.00	0.00	0.24
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	37.47	14.08	5.69	2.59	0.83	0.62	0.72	0.41	0.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	60.19	16.52	6.08	3.61	2.47	0.57	0.95	0.76	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	37.04	14.33	7.69	7.34	1.05	3.15	2.10	1.05	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	30.88	16.03	1.17	0.78	3.13	0.39	0.78	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	90.50	24.09	7.88	5.85	3.04	1.01	1.13	0.56	1.01
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	37.70	13.56	2.97	0.85	1.27	0.00	0.85	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	69.38	11.42	5.08	2.54	1.27	0.42	0.00	0.42	0.42
stomach, fetal, donor1	10062-101H8	58.74	20.29	3.20	0.00	0.00	0.00	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	83.74	21.65	2.85	2.28	2.85	0.57	1.14	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	217.10	271.37	976.93	759.84	54.27	0.00	162.82	54.27	0.00
substantia nigra, adult, donor10252	10158-103A5	74.36	20.36	12.67	8.52	2.70	2.08	2.70	1.87	0.42
substantia nigra, adult, donor10258	10371-105G2	45.52	15.52	7.76	7.24	0.00	2.59	1.03	0.52	0.52
substantia nigra, newborn, donor10223	10358-105E7	67.12	12.72	4.24	0.71	1.41	0.00	0.71	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	72.68	14.90	10.55	6.19	2.29	1.15	1.38	0.46	0.46
temporal lobe, adult, pool1	10031-101E4	25.18	6.78	0.42	0.08	0.68	0.25	0.00	0.17	0.34
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	70.51	26.35	0.71	3.56	2.14	1.42	0.71	1.42	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	76.48	29.01	2.64	2.20	1.32	0.00	1.32	0.44	0.44
tenocyte, donor1	11763-123H8	19.20	8.03	3.14	3.14	0.35	0.70	1.40	0.35	0.00
tenocyte, donor2	11765-123I1	19.84	5.34	3.82	1.91	0.00	0.00	0.76	1.14	0.00
tenocyte, donor3	11768-123I4	22.24	8.15	2.97	2.22	0.74	1.11	1.11	1.85	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	94.84	37.73	18.87	9.86	3.57	1.87	2.38	1.70	0.68
teratocarcinoma cell line:NCR-G1	10798-110I6	38.69	14.80	4.01	1.23	1.08	0.77	0.62	0.15	0.15
teratocarcinoma cell line:PA-1	10807-111A6	49.28	14.26	3.41	2.32	2.32	0.77	0.46	0.62	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	60.05	17.26	4.95	2.54	2.03	1.40	0.38	0.51	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	102.48	21.93	13.24	8.32	2.27	0.76	1.51	1.51	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	68.27	22.79	4.25	4.47	2.51	0.22	0.87	1.20	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	59.93	13.03	26.38	15.63	4.23	8.79	3.91	4.89	0.65
testis, adult, pool1	10026-101D8	34.47	12.78	1.83	1.18	2.25	0.32	0.21	0.21	0.11
testis, adult, pool2	10096-102C6	33.38	24.36	8.12	6.32	1.80	3.61	2.26	1.35	0.90
thalamus - adult, donor10196	10168-103B6	70.66	24.29	6.62	2.21	2.21	0.00	0.00	1.10	0.00
thalamus, adult, donor10252	10154-103A1	78.77	22.66	14.38	7.81	3.44	2.19	1.88	2.66	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	97.00	49.27	6.16	20.02	1.54	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	27.83	11.86	2.47	2.14	0.49	0.16	0.49	0.49	0.33
thalamus, newborn, donor10223	10366-105F6	33.37	8.05	1.73	0.58	1.15	1.15	0.00	0.58	0.00
throat, adult	10209-103G2	55.93	13.48	1.25	1.00	1.25	1.25	0.25	0.25	1.00
throat, fetal, donor1	10061-101H7	67.95	12.19	4.88	2.44	0.30	0.00	0.61	0.61	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	64.59	9.74	3.97	2.98	1.39	0.99	0.40	0.40	0.20
thymus, adult, pool1	10027-101D9	102.40	18.99	2.98	1.09	2.68	0.10	0.20	0.40	0.89
thymus, fetal, pool1	10043-101F7	125.62	24.00	2.70	2.60	4.68	0.42	0.52	0.10	0.83
thyroid carcinoma cell line:KHM-5M	10776-110G2	34.84	12.63	2.13	1.46	0.93	0.27	0.27	0.27	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	44.14	18.72	5.17	3.07	1.26	1.54	0.56	1.40	0.00
thyroid, adult, pool1	10028-101E1	64.11	11.76	3.27	1.03	2.15	0.37	0.37	0.00	0.19
thyroid, fetal, donor1	10060-101H6	81.74	15.03	11.07	7.65	2.64	1.85	1.85	0.53	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	61.59	12.32	6.16	6.16	3.08	3.08	0.00	0.00	0.00
tongue, adult	10203-103F5	45.59	12.56	3.72	3.72	0.93	2.56	0.47	0.70	0.00
tongue, fetal, donor1	10059-101H5	33.10	9.46	6.31	1.97	0.39	0.79	0.39	0.39	0.39
tonsil, adult, pool1	10047-101G2	57.00	10.42	0.20	0.50	1.70	0.40	0.10	0.10	0.60
trachea, adult, pool1	10029-101E2	53.50	14.97	0.98	0.82	2.29	0.33	0.16	0.08	0.08
trachea, fetal, donor1	10058-101H4	49.63	13.08	3.46	1.92	0.77	1.15	0.77	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	26.22	9.57	2.48	1.77	0.35	0.71	0.00	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	92.70	21.28	2.53	1.32	2.94	0.51	0.20	0.41	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	47.32	18.02	9.56	5.01	2.19	0.16	1.10	0.94	0.16
tridermal teratoma cell line:HGRT	10694-109G1	26.64	5.71	1.90	1.90	0.00	1.90	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	25.31	11.85	2.79	1.69	0.93	0.85	0.68	0.34	0.08
umbilical cord, fetal, donor1	10057-101H3	20.87	6.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	55.62	15.70	1.02	0.68	1.37	0.17	0.00	0.00	0.34
uterus, fetal, donor1	10055-101H1	41.47	15.36	4.10	2.05	2.05	0.51	1.54	1.02	0.00
vagina, adult	10204-103F6	53.63	7.11	0.65	0.65	1.94	0.65	0.00	0.00	0.00
vein, adult	10191-103E2	39.89	14.25	1.75	1.10	2.63	0.22	0.00	0.00	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	35.52	13.62	4.54	2.67	1.07	1.60	0.27	0.80	0.27